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The term ‘quorum sensing’ (QS) is used to define a population density based 
communication mechanism which uses chemical signal molecules called autoinducers 
to trigger unique and varied changes in gene expression.  Although several 
communication methods have been identified in bacteria that are unique to a 
particular species, one type of signal molecule, autoinducer-2 (AI-2) is linked to 
interspecies communication, indicating its potential as a universal signal for cueing a 
QS response among multiple bacterial types.  In E. coli, AI-2 acts as an effector by 
binding to the QS repressor LsrR.  As a result, LsrR unbinds and relieves repression 
of the lsr regulon, stimulating a subsequent QS gene expression cascade.    
In this dissertation, LsrR structure and in vitro binding activity are examined.  
Genomic binding and DNA microarray analyses are conducted and three novel sites 
putatively regulated by LsrR, yegE-udk, mppA and yihF, are revealed.  Two cAMP 
  
receptor protein (CRP) binding locations in intergenic region of the lsr regulon are 
also confirmed.  The role of each CRP site in divergent expression is qualified, 
indicating the lsr intergenic region to be a class III CRP-dependent promoter.  Also, 
four specific DNA binding sites for LsrR in the lsr intergenic region are proposed, 
and reliance upon simultaneous binding to these various sites and the resulting effects 
on LsrR repression is presented.  Finally, a complex model for regulation of the lsr 
regulon is depicted incorporating LsrR, CRP, DNA looping, and a predicted 
secondary layer of repression by an integration host factor (IHF)-like protein.  Further 
understanding of this QS genetic mechanism may potentially be used for inhibiting 
bacterial proliferation and infection, modifying the natural genetic system to elicit 
alternate desired responses, or extracted and applied to a highly customizable and 
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Chapter 1: Communication in Bacteria  
 
1.1 Introduction 
The bacterial signal transduction process through which gene expression may be 
directly or indirectly affected has gained increasing focus since the mid-1980s when 
previously unrelated proteins were shown to be expressed during a sophisticated 
subsequent genetic response [1, 2].  These complex reactions in what were 
historically considered ‘simple’ prokaryotic organisms in a wide variety of 
environmental conditions range from nearly undetectable to drastic [3].  For example, 
this response cascade permits the marine bacteria, Vibrio fischeri, which can inhabit 
light organs of some marine animals, to bioluminate; however, this effect only 




 CFU/ml [4, 5].   
The term quorum sensing (QS) was first used by Fuqua et al. [5] to define a 
population density based communication mechanism which uses chemical signal 
molecules called autoinducers to trigger unique and varied changes in gene 
expression.  Various communication methods have since been identified which 
employ a variety of autoinducers to effect such changes within species.  Furthermore, 
autoinducer-2 (AI-2) has been linked to interspecies communication, indicating its 
potential as a ‘universal’ signal for QS circuitry among multiple bacterial species or, 
potentially, between prokaryotes and eukaryotes [6-8].  This universality suggests not 




outcomes in vivo, but also for extracting desired components of a versatile system and 
using them in their native state, or potentially applying them for in vitro use [9].  
In the health industry, antibiotic-resistant bacteria continue to emerge at 
alarming rates and all aspects of the infection process are being re-examined so that 
new procedures for prevention, diagnosis, and treatment of bacterial infections can be 
developed that reduce their occurrence and severity as well as the economic impact 
on health care systems. One of the most problematic pathogens is methicillin-resistant 
Staphylococcus aureus (MRSA). First reported among intravenous drug users in 
Detroit, MI (USA) in 1981 and later associated with the deaths of four children in 
Minnesota in 1997, MRSA was reported to be the cause of a staggering 85% of health 
care-associated infections in 2007 as well as the most common origin of skin and 
tissue infections presented to hospital emergency rooms in the United States [10]. 
These statistics illustrate the scale and impact that bacteria can have on a population 
and our health care system, and the importance of understanding the QS process 
through which pathogens such as MRSA may proliferate [9].   
Contrary to the once common perception that bacteria operate as autonomous 
unicellular entities, recent work has demonstrated that they actually employ highly 
specific intercellular communication networks.  The promising potential exists for 
modification of the QS systems; for example, multi-component QS networks, when 
targeted by drugs, become disabled so bacteria can survive but in a less lethal mode 
[11-13].   Still, the extremely selective and often staggeringly complex nature of the 
QS response cascades has resulted in many incompletely understood intracellular 




cascade is nominally identified, its exact function and significance often remains 
unknown [9].   
As previously discussed, autoinducer-2 (AI-2) signaling is regarded as a 
‘universal’ bacterial communication system due to its capability to prompt population 
based changes in multiple species of both Gram-positive and Gram-negative bacteria. 
First examined after mid-exponential phase cell supernatant from Salmonella 
typhimurium was shown to trigger a QS response (in the form of bioluminescence) in 
Vibrio harveyi, AI-2 later gained recognition as a sort of ‘bacterial  Esperanto’, 
synthesized by LuxS and its homologues in multiple bacterial strains and evoking 
considerable changes in gene expression [14-16].  Taga et al. [17, 18] linked LuxS 
and AI-2 in Salmonella typhimurium to the expression of the lsr (LuxS-regulated) 
operon, encoding an ATP binding cassette (ABC)-type transporter determined to be 
responsible for the uptake of AI-2 into the cells. The divergent gene set was also 
shown to encode its cognate repressor, LsrR which was, in turn, ineffective in the 
presence of AI-2 [9].   
However, low levels of native AI-2 detected in cell lysates led to the 
speculation that the signal molecule was somehow modified after uptake and that 
native AI-2 did not affect LsrR repression. It was later demonstrated in Escherichia 
coli that the kinase, LsrK, is directly responsible for the post uptake modification of 
AI-2, and the resulting intracellular phospho-AI-2 provoked de-repression of the lsr 
operon via LsrR [19, 20].  In deciphering expression of the lsr operon and its 
subsequent impact throughout the bacterial genome, focus has shifted to a systems 




other physical processes.  Li et al. [21] showed the importance of LsrR as not only a 
determinant of lsr expression, but as a regulator of hundreds of genes, many of which 
would likely be involved in virulence processes such as motility and biofilm 
formation [9].   
With the significance of LsrR emerging, Xue et al. [22] evaluated the exact  
binding site for the repressor via DNA footprinting and protein binding assays.  LsrR 
was shown to bind two separate sites within the intergenic region of the lsr operon, 
repressing transcription in opposite directions. Also, LsrR binding was apparently 
unaffected by the presence of native AI-2; increasing levels of phospho-AI-2, 
however, resulted in proportionate decreases in LsrR binding [22]. These results 
confirmed that the AI-2 must be modified by LsrK prior to antagonizing the cognate 
repressor.  The direct regulation of the lsr operon by LsrR reaffirms the suspicion 
from Li et al. [21] that LsrR serves as an important ‘global’ regulator of AI-2 quorum  
sensing in bacteria [9].   
Cued as a single signal regulator but with wide genetic impact, LsrR 
represents a promising new avenue for deciphering the complex nature of QS.  
Moreover, it represents another target for drug therapies which fight bacterial 
infection by preventing intercellular communication.  Further progress will depend on 
a full understanding of LsrR and its effects on gene expression as well as the 
subsequent physiological changes spurred by its regulation.  By continuing to dissect 
and understand biological signal transduction cascades, tools may then be devised 
increasing efficacy of tasks ranging from reducing pathogenicity of common bacterial 




extraction and optimization of mechanisms for environmental sensing and detection 
devices [9].   
1.2 Background: Bacterial Communication 
In the last 15 years, it has become evident that prokaryotes actually employ 
several modes of highly selective and relatively refined intercellular communication 
methods [23].  Two common types of signal systems in bacteria, two-component 
regulatory systems and QS systems, effect a signal transfer across the cell membrane 
[24].  Both systems are composed of a transmembrane signal transfer protein and 
correlating regulator protein which reacts to a specific trigger.  However, in two-
component systems the extracellular signal molecule is not normally taken up by the 
cell, while in QS systems the signal molecule will typically be transferred across the 
cell membrane and initiates a change in gene expression through direct interaction 
with regulatory proteins [24, 25].     
In QS systems, the signal molecule is both produced and taken up by the cell, 
varying its intracellular and extracellular concentration [5, 20, 26, 27]. As cell density 
increases in a confined space, the extracellular concentration of the signaling 
molecule reaches a stimulating threshold, triggering the transduction cascade and 
resulting in a population-dependent shift in gene expression [19, 21].   
Three types of QS systems have been defined which are based upon the type 
of signaling molecule involved: 
Acyl-homoserine lactone (AHL) signaling, also known as autoinducer-1 (AI-1) 
signaling, is the predominant communication method among Gram-negative bacteria  




forms will vary among species (Figure 1-1A) [28-30].  Synthesized AHL begins to 
accumulate in the bacterial environment, passively or, more rarely, actively diffusing 
through the cell wall and eventually reaching a threshold concentration, stimulating 
binding to a LuxR-type sensor kinase protein.  The LuxR-AHL complex then binds to 
and promotes expression of the lux (or analogous) operon [11, 31].  
 
Oligopeptide signaling is utilized by Gram-positive bacteria, during which a peptide 
approximately 5 to 17 amino acids in length (Figure 1-1B) is synthesized and actively 
exported by ATP-binding cassette type transporters [4, 8, 32]. The extracellular 
peptide then initiates a chain reaction of phosphorylations via additional systemic 
proteins, until finally a DNA binding protein is modified and activated, controlling 
gene transcription [23].  
 
            




Figure 1-1.  Intraspecies communication molecules.  
(A) Acyl-homoserine lactone (AHL) molecule.  R: -H, -OH, or =O; n: 3-11.  (B) 




Autoinducer-2 (AI-2) signaling is regarded as a ‘universal’ bacterial communication 
system due to its capability to instigate population-based changes in genetic 
expression among multiple species of both Gram-positive and Gram-negative bacteria 
[8, 15, 33].  Able to trigger cross-species QS responses, homologues of AI-2 have 
since been identified in more than 70 bacterial species [34]. AI-2 is synthesized from 














(A)         (B) 
 
Figure 1-2.  Synthesis of autoinducer-2 from S-adenosylmethionine (SAM). 
(A)  SAM is converted to SAH and SRH to synthesize DPD.  Adapted from Wang et 




phospho-DPD, but quickly degrades in solution to form 2-phosphoglycolic acid (PG) 
[12]. 
 
In E. coli, AI-2 is secreted from the cell and accumulates in the extracellular 
environment, where it is in turn transported back into the cell passively via diffusion 
or actively via LsrACDBFG (Figure 1-3).  Upon reentry into the cell, AI-2 is 
phosphorylated by the kinase LsrK, and the resulting phospho-AI-2 complex 
purportedly antagonizes the lsr repressor protein LsrR, de-repressing transcription of 
the lsr operon [21, 22, 27].  Once repressor activity is negated, transcription of genes 









SAH is converted to SRH and DPD by Pfs and LuxS.  DPD then spontaneously 
cyclizes to form AI-2, which is secreted and imported via LsrACDB.  After 
phosphorylation by LsrK, the phopsho-AI-2 complex antagonizes the repressor LsrR, 
permitting expression in the lsr operon.  Source: Wang et al. [27] 
1.3 Research Motivation 
The AI-2 based QS has garnered significant attention in the last twenty years and 
progress in understanding the genetic circuitry involved in the QS process revealed its 
connection to myriad genetic and phenotypic attributes including virulence [32, 35], 
sporulation [11, 29], motility [36, 37], biofilm formation [38, 39], and cell growth 
[13, 40].  Extensive studies of enterohemorrhagic E. coli (EHEC) O157:H7 showed 
that AI-2 directly induced the virulence genes LEE1-LEE3 and tir, and that roughly 
10% of the genome is subsequently differentially transcribed as a response to the QS 
process [4, 37].  Similar studies in E. coli K12, S. typhimurium, and V. harveyi have 
also shown the potential global genetic impacts of QS [17, 18, 20, 21, 41]. 
 Examining bacterial virulence as a result of quorum sensing is progressing in 
tandem with the study of biofilm formation.  Involved in approximately two-thirds of 
bacterial infections and offering a safe haven for cellular proliferation in an otherwise 
hazardous environment, biofilms are now understood to often host multiple bacterial 
species simultaneously in an intricate and interdependent physical matrix [42, 43].  
The role of AI-2 in eliciting biofilm formation was examined by Barrios et al. [38] 
through the addition of the quorum sensing molecule to mutant strains.     
Much has been accomplished in elucidating specific elements of the QS 




uptake, and phosphorylation of AI-2 [12, 44, 45], or the potential role of LsrFG in the 
breakdown of phospho-AI-2 [18].  The current model of the QS signal transduction 
circuit shows the lsr repressor, LsrR, to be a single point of action that, once 
antagonized, prompts the QS transcription cascade to begin.  However, though the 
basic function of LsrR is known, the exact mechanisms and characterization of the 
repressor are still being evaluated [9, 22].    
 The QS process holds great potential for use in various fields.  For example, 
artificially ceasing QS may help to fight infection, reducing the need for the use of 
antibiotics.  Also, the food production industry seeks to harness the QS detection 
process in order to provide for the detection of food-borne pathogens [4, 29, 46, 47].   
A more thorough understanding and successful application of the QS circuit demands 
further investigation of LsrR and its exact mechanism of repression in the lsr 
intergenic region.   
 
1.4 Literature Review of LsrR 
Although LsrR was shown, in the absence of AI-2, to repress transcription of the lsr 
operon in 2001 [17], it was not until 2005 that Taga et al. [18] first suggested that AI-
2 requires phosphorylation prior to antagonizing LsrR.  After this catalyst for 
relieving the repression of the lsr regulon by LsrR was explored, in 2007 the global 
impact of the repressor was examined using DNA expression microarrays.  These 
data suggested that LsrR did, as seen in other organisms, have a widespread effect 
during the QS process, with 67 genes differentially regulated by LsrR and an 




 Still, by 2009 the binding sites and regulatory mechanism by which LsrR 
effected repression in the lsr regulon or elsewhere had not been explored.  While 
DNA binding analyses and motif confirmation are commonly investigated using in 
vitro assays, the challenges of in vitro work with LsrR (discussed further in Chapter 
2) may have inhibited rapid discovery of binding locations.  Xue et al. [22] reported 
success with localizing LsrR binding to two general locations in the lsr intergenic 
region, each within 50 bp upstream of the lsrR and lsrA start sites.  Also reported was 
the first in vitro response of LsrR to phospho-AI-2 and its subsequent dissociation 
from DNA [22].  
 In 2010, although LsrR or its homolog had been indicated to have widespread 
impact in multiple species including E. coli [21], S. typhimurium [18], and V. harveyi 
[48], Thijs et al. [49] used chromatin immunoprecipitation in conjunction with 
microarrays (ChIP-Chip) in S. typhimurium to show, surprisingly, a single LsrR 
binding location within the lsr set of genes.  These data, however, may be vulnerable 
to over- or underrepresentation of actual binding events for multiple reasons [50], and 
are discussed further in Chapter 3.   
 LsrR continues to be characterized, and in 2010 preliminary crystallographic 
analysis of the repressor was reported, estimating its structure to contain two protein 
molecules per asymmetric unit [51, 52].  Multimerization of a DNA-binding protein 
is not uncommon [53-55], and while the dimeric form reported for an overexpressed, 
his-tagged LsrR is unsurprising, the in vivo form during which full repression is 







1.5 Global Objective, Global Hypothesis, and Specific Aims 
The global objective of this dissertation is to further investigate the regulation of 
expression as a result of the QS cue in E. coli.   
Global Hypothesis: LsrR displays complex global and local regulatory binding. 
Specific Aim 1:  Assess LsrR activity and potential use in vitro.  
Specific Aim 2:  Determine specific binding sites for LsrR outside of the lsr region in 
vivo. 
Specific Aim 3:  Describe the mechanism of LsrR binding and repression and assess 
the role of cAMP-CRP in the lsr intergenic region.  
 
 
1.6 Dissertation Outline 
Chapter 2 describes the expression and purification of LsrR and in vitro assays used 
in order to assess CRP and LsrR binding activity.  Various conditions for LsrR 
growth, purification methods, and plasmid constructs are described.  cAMP receptor 
protein (CRP) binding analyses and methods are also shown.   
Chapter 3 includes the global binding analysis for LsrR using DNA 
microarrays and discusses the potential impacts of the various binding sites.  
Directional expression analysis of the divergent lsr regulon is also included, and 




Chapter 4 describes and examines putative LsrR binding sites and describes a 
model for repression in the lsr intergenic region, incorporating LsrR, CRP, and DNA 
as a regulatory complex with an introduction to an additional integration host factor 
(IHF)-like regulatory mechanism in the lsr regulon.   
Chapter 5 discusses current and potential future work applicable to LsrR and 










In current models of the quorum sensing (QS) system, the repressor LsrR is the single 
point of relief for negative regulation of the lsr regulon and dissociates from the 
intergenic DNA after antagonization by the phosphorylated form of the 
communication molecule autoinducer-2 (AI-2).  Once the lsr regulon is de-repressed, 
cyclic-AMP receptor protein (CRP) activates transcription of the divergent lsr gene 
set by binding upstream from transcription start sites and recruiting RNA polymerase 
holoenzyme (RNAP) to the region.  In this study we construct a plasmid vector 
encoding LsrR in order to harvest the repressor for in vitro analysis, and use 
electrophoretic mobility shift assays (EMSA) to evaluate LsrR and CRP binding 
affinity to the lsr intergenic region.  While LsrR demonstrated minimal in vitro 
binding activity under the tested conditions, CRP was confirmed to have two distinct 
binding sites in the lsr intergenic region with similar binding affinity despite the 














The QS repressor LsrR has been shown to negatively regulate expression in the lsr 
regulon of E. coli and S. typhimurium by binding to and inhibiting expression of the 
divergent gene set [17, 18, 21, 22].  After the QS molecule AI-2 is taken up by the 
cell and phosphorylated by LsrK, the resulting phospho-AI-2 complex antagonizes 
LsrR, resulting in its dissociation from the lsr intergenic region and subsequent 
expression of the lsr genes [18, 27, 44].   
 The impacts of LsrR on global genetic expression have been evaluated in E. 
coli K12, S. typhimurium, and V. harveyi, and numerous genes are confirmed to be 
differentially regulated as a result of LsrR activity [17, 18, 20, 21, 41].  However, in 
S. typhimurium chromatin immunoprecipitation in conjunction with DNA 
microarrays (ChIP-Chip) data showed only a single genomic binding location for 
LsrR, located in the lsr operon [49].  This discrepancy in binding locations versus 
differential regulation may be due to various causes.  For example, the dissociation of 
LsrR from the lsr intergenic region may instigate a secondary regulatory cascade with 
alternate transcriptional regulators contributing to gene activation [56, 57].  
Alternatively, inherent error in the ChIP-Chip process or complex protein-DNA 
interactions during LsrR repression may prevent harnessing of the repressor and 
underrepresent actual in vivo binding events [50, 58, 59].   
 The E. coli cyclic-AMP reception protein (CRP) activates gene transcription 
at over 100 promoters by binding to regions upstream of gene start sites and 
recruiting RNA polymerase holoenzyme (RNAP) to the location, subsequently 




binds to regions which overlap promoter segments, resulting in RNAP inhibition and 
acting to negatively regulate expression in those genes [63-65].  CRP changes 
conformation by interacting with the effector cyclic-AMP, after which it may bind to 
its consensus sequence (primary binding sites in bold):  
(5’-AAATGTGATCTAGATCACATTT-3’) [60].  Two separate CRP binding 
locations have been previously identified in the lsr intergenic region and expression 
analysis of the divergent genes in the absence of CRP (by preventing intracellular 
cAMP availability through the addition of glucose) demonstrated a precipitous drop 
in expression of both gene sets [20, 27].   
Studies involving DNA-binding proteins commonly use electrophoretic 
mobility shift assays (EMSA) in order to test protein binding affinity to various native 
or mutated DNA fragments [66-68].  Although two CRP sites were identified in the 
lsr intergenic region, neither binding location region carries the complete consensus 
sequence indicated above.  In this study, we evaluate CRP binding to the two regions 
and compare binding affinity to the differing sequences and search the remainder of 
the intergenic region for possible additional CRP binding sites.  Additionally, because 
the data for LsrR binding and global impact in S. typhimurium are apparently deviant, 
in this study we also construct a plasmid for overexpression and purification of LsrR, 
and focus on DNA binding activity by using various sections of the lsr intergenic 
region.  Finally, we conduct preliminary analysis of LsrR secondary structure using 







2.3 Materials and Methods  
 
Bacterial strains, plasmids, and growth conditions. 
E. coli strains used in this work are described in Table 2-1.  All cultures were grown 
aerobically at 37°C in Luria-Bertani (LB) media or as specified.  Media were 
supplemented as necessary with antibiotics at the following concentrations: 
ampicillin, 50µg ml
-1




Plasmid construction.  Plasmids and primers used in this study are listed in Table 2-
1.  Chromosomal DNA was purified from E. coli MG1655 (DNeasy tissue kit, 
Qiagen, CA, US) and used as the template for all PCR reactions.  LsrR was expressed 
and purified by constructing a TOPO® clone using the pET200 vector (Invitrogen, 
CA, US).  Briefly, the 954 bp open reading frame (ORF) for lsrR (NC_000913, 
1598312…1599265) was amplified via PCR from an E. coli K-12 whole genome 
sample using SYBR green PCR master mix (Applied Biosystems, CA, US).  Both 
plasmid and PCR product insert were digested with NheI and MfeI restriction 
enzymes (NEB, MA, US), and pET200LsrR was assembled using a quick ligation kit 
(NEB).  Ligated plasmids were transformed into chemically competent TOP10 E. coli 
(Invitrogen) and cultured as specified previously.  Construct sequences were 
confirmed via sequencing at the DNA core facility of the Center for Biosystems 
Research (University of Maryland Biotechnology Institute). 
 
Protein Purification.  CRP samples were supplied by Fred Schwarz, University of 









 Source or Ref. 
   
E. coli strains   
   K12 MG1655 Wild type Laboratory stock 
   BL21DE3 1. fhuA2 [lon] ompT gal (λ DE3) [dcm] 0hsdS NEB 
   TOP10 F
-
mcrA ∆(mrr-hsdRMS-mcrBC) φ80lacZ∆M15 ∆lacΧ74 recA1 araD139 ∆(ara- Invitrogen 




   pET200LsrR expression vector encoding lsrR with N-terminus 6xHis-tag, Kan
r
 Invitrogen 
   
Primers   
   plsrRFWD CACCATGACAATCAACGATTCGGCAATTTC This study 
   plsrRREV TGCTGTGTCCTGATCGGTAACCAGTGCGTT This study 
   lsrIGF ATTTCCCCCGTTCAGTTTTGCAGGTGAG This study 
   lsrIGR TAAATCTTTAATGCAATTGTTCAGTTCT This study 
   crpbsAF ATTTCCCCCGTTCAGTTTTGCAGGTGAGTTTTGAACAAATGTATTTCTGC This study 
   crpbsAR GCAGAAATACATTTGTTCAAAACTCACCTGCAAAACTGAACGGGGGAA This study 
   crpbsBF TTTTAATTTGTTCATAACCTTAGGTGGACATTGCACATATTTCCGACGA This study 
   crpbsBR TCGTCGGAAATATGTGCAATGTCCACCTAAGGTTATGAACAAATTAAA This study 
   crpbsCF TAGATCACAATTTATGCTATTTTGATTTTCACGGTTGCGTTTGTTCATGC This study 
   crpbsCR GCATGAACAAACGCAACCGTGAAAATCAAAATAGCATAAATTGTGATC This study 
   crpbsDF TCGTAGAGTCAAACTGTGGTTGCCATCACAGATATAAATGAGCAAGAA This study 
   crpbsDR AGTTCTTGCTCATTTATATCTGTGATGGCAACCACAGTTTGACTCTACG This study 
   crpbsEF GAACAATTGCATTAAAGATTTAAATATGTTCAAAGTGAAGAATGAATT This study 
   crpbsER AATTCATTCTTCACTTTGAACATATTTAAATCTTTAATGCAATTGTTC This study 
   crpbs1F GAGTTTTGAACAAATGTATTTCTGCTTTTAATTTGTTCATAACCTTAGGT This study 
   crpbs1R ACCTAAGGTTATGAACAAATTAAAAGCAGAAATACATTTGTTCAAAAC This study 
   crpbs2F GGACATTGCACATATTTCCGACGAATAGATCACAATTTATGCTATTTTG This study 
   crpbs2R TCAAAATAGCATAAATTGTGATCTATTCGTCGGAAATATGTGCAATGTC This study 
   crpbs3F TTTTCACGGTTGCGTTTGTTCATGCTCGTAGAGTCAAACTGTGGTTGCC This study 
   crpbs3R TGGCAACCACAGTTTGACTCTACGAGCATGAACAAACGCAACCGTGAA This study 
   crpbs4F TCACAGATATAAATGAGCAAGAACTGAACAATTGCATTAAAGATTTAA This study 







purified from an overnight culture of TOP10+pET200LsrR using a SpinPrep 
Miniprep Kit (Qiagen, CA, US).  The pET200LsrR vector was then transformed into 
chemically competent E. coli BL21DE3 (NEB) and cultured as previously described.  
When the optical densities (OD600) of the cell cultures reached 0.4, growth media 
were supplemented with 1mM IPTG in order to induce protein production.  After 4 
hours of growth, cells were collected by centrifugation at 5,000 xg for 20 minutes at 
4°C.  The cell pellet was resuspended in the Bugbuster protein extraction reagent 
(Merck, GE) and shaken at 100 rpm at room temperature for 20 minutes in order to 
lyse cells.  Samples were centrifuged at 1500xg at 4°C for 20 minutes in order to 
separate the inclusion body.  Supernatant was collected, and 25 units of Benzonase 
(Merck) were added per ml of supernatant in order to reduce viscosity.  The 
pET200LsrR plasmid encodes a hexahistidine tag (6xHis) onto the N-terminus of 
LsrR.  Purification of His-LsrR was done using Ni-charged His-bind resin kit 
(Novagen) with affinity to the 6xHis tag.  Briefly, resin beads were washed (0.5M 
NaCl, 120mM imidazole, 40mM Tris-HCl, pH 7.9) and charged (50mM NiSO4) and 
resulting slurry was added to cell lysate and allowed to incubate on a rotating shaker 
at 4°C for 4 hours.  Resin beads were separated by centrifugation at 100 rpm at room 
temperature.  Beads were then washed thoroughly (0.5M NaCl, 120mM imidazole, 
40mM Tris-HCl, pH 7.9) and protein was eluted using the supplied elution buffer 
(0.5M NaCl, 1M imidazole, 20mM Tris-HCl, pH 7.9).  For gradient elution analysis, 
washes of LsrR-bound beads were conducted three times with wash buffer (0.5M 
NaCl, 40mM Tris-HCl, pH 7.9) with 120mM, 300mM, and 600mM of imidazole in 





Electrophoretic Mobility Shift Assays (EMSA).  For EMSA with LsrR, the entire 
248 bp lsr intergenic region was amplified via PCR using primers lsrIGF and lsrIGR 
(IDTDNA, IA, US).  DNA was purified using a Quick PCR purification kit (Qiagen).  
For DNA preparation for EMSA with CRP, the lsr intergenic region was segmented 
into 50 bp overlapping sections (Figure 2-1A).   
To construct dsDNA corresponding to each section, appropriate ‘crpbs’ 
primers listed in Table 2-1 were annealed by adding 10mM of each forward and 
reverse primer to 100 ul of annealing buffer (10mM Tris-HCl, 100 mM NaCl, 1mM 
EDTA, pH 7.5).  Binding reactions included 10µM of CRP or 10-100µM of His-LsrR 
with 300 ng of appropriate DNA segments in a binding buffer containing 10mM Tris-
HCl, 50mM KCl, 1mM EDTA, 1mM DTT.  EMSA assays with CRP also included 
100µM cAMP, and assays with LsrR included 30µM of unphosphorylated AI-2.  
Additionally, LsrR was grown in BL21DE3∆luxS in order to eliminate the presence 
of endogenous AI-2, preventing any phospho-AI-2 from binding to the purified LsrR 
during growth.  Samples were run on a non-denaturing 8% Tris-HCl polyacrylamide 
gel (Bio-rad) in Tris-glycine buffer (25 mM Tris, 190 mM Glycine, pH 8.3) at 120V 




Intergenic region carries two CRP binding sites with similar affinity.  EMSA was 




combined with segments ‘2’ and ‘D’ showed the most significant shift and 
corresponds to previously reported CRP binding sites [20, 27].  Each of these two 
duplexes carry the entire CRP binding motif indicated for that site and display 
comparable magnitudes of shift, indicating a similarity in binding affinity for CRP 
despite the variation in sequence between the two (Figure 2-1B).  Band intensity 
analysis using Quantity One software Version 4.6.5 shows magnitudes of shifted 




Figure 2-1.  EMSA analysis of CRP.   
(A) Each bracketed segment includes the 50 bp duplex section of the lsr intergenic 
region used in EMSA with CRP.  Vertical arrows indicate locations of CRP binding 
sites I and II [20, 27].  For EMSA, 300 ng of intergenic DNA segments from (A) 
were incubated with 10µM of CRP in 20µl of EMSA binding buffer (10mM Tris-
HCl, 50mM KCl, 1mM EDTA, 1mM DTT) for 10 minutes at room temperature.  (B) 
Non-denaturing PAGE gel analysis shows significant, similar shifts of DNA 
segments ‘2’ and ‘D’ confirming presence of two CRP binding sites with similar 
affinity.  Less prominent shifts seen with segments ‘B’ and ‘4’ are presumed to be 
due to the presence of half of the CRP binding site.  Gel was stained with SYBR 
Green nucleic acid gel stain.  (C) CRP binding motifs within segments ‘2’ and ‘D’.  
Bold letters indicate sequences that are also included on adjacent (Segments ‘B’ and 


























   Duplex ‘2’ 
 -92 
  TCCGAcgaatagaTCACA 
 
 
     Duplex ‘D’ 
  -165 




Additionally, a lesser, but still noticeable DNA shift is present in lanes ‘B’ 
and ‘4’.  Each of these sections carries half of the adjacent CRP binding site, with 
sections ‘B’ and ‘4’ having sequence ‘TCCGAcgaa’ and ‘TCACA’, respectively 
(Figure 2-1C) and likely minimal CRP binding results in the partial observed shift.   
 
More than 95% LsrR remains in inclusion body after purification.  LsrR was 
grown and purified as described in Materials and Methods, and various volumes of 
eluate were examined using SDS-PAGE.  Flamingo protein stain of gel shows 
undetectable levels of LsrR in eluate volumes of 5µl and 10µl, with only minimal 
levels of LsrR present in the 20µl column (Figure 2-2A).   
 Since LsrR purification yielded low levels of protein, gradient elutions using 
wash buffers with increasing amounts of imidazole were conducted in order to assess 
whether the bound LsrR was dissociating from the purification beads during washing.  
Also, the inclusion body formed during purification was analyzed using PAGE-SDS 
in order to see if LsrR was precipitating out of solution.  Figure 2-2B shows gradient 
washes 1-3, elution ‘E’, and inclusion body (IB) of the LsrR purification process.  In 
each sample 1-3, low levels of LsrR are detectable in solution but, as compared to the 
final elution, demonstrate a significant loss of overall soluble protein during washing.  
Prominent band at the theoretical LsrR size of 37kDa in inclusion body column 
(horizontal arrows in Figure 2-2B) also shows a loss of the majority of LsrR during 



















Figure 2-2.  LsrR purification analysis.   
(A) Flamingo protein stain of 5µl, 10µl, and 20µl volumes of LsrR purification 
elution in denaturing SDS-PAGE gel.  LsrR only becomes detectable with 20µl of 
eluate.  (B)  20µl of washes 1-3 and elution ‘E’ of protein purification beads.  ‘IB’ 
shows 1µl of inclusion body resuspended in 20µl PBS.  Prominent band in ‘IB’ 
column shows presence of majority of His-LsrR.  Theoretical size of LsrR is 37kDa 
(horizontal arrows).  ‘L’ in each gel is 8µl is Precision Plus Protein standard (Biorad).  
L           5µl         10µl         20µl 




0o D0A binding activity detectable in vitro with 0-terminus His-tagged LsrR.  
Although low levels of soluble LsrR were available after purification, sensitivity of 
EMSA assays permit in vitro analysis using similar samples [67, 69].  EMSA with 
LsrR was conducted under the same conditions used for CRP.  Due to its potential 
role as an activator for LsrR, 30µM AI-2 was also added [18, 27, 34, 70].   
Increasing levels of LsrR showed no in vitro binding activity when combined 
with the lsr intergenic region (Figure 2-3A).  Nucleic acid stains of EMSA PAGE 
gels displayed no shift or other drop in magnitude as compared to the ‘DNA only’ 
lane indicating a lack of affinity for the tested DNA segments under conditions used.  
In order to evaluate the possibility that CRP binds to the lsr intergenic region and 
recruits or facilitates LsrR binding, we conducted another EMSA using the lsr 
intergenic region, 10µM LsrR, and 8µM CRP (Figure 2-3B).  Results again show no 
shift with the DNA-LsrR only sample and a significant shift in the CRP-DNA lane 
(lanes 3 and 4 in Figure 2-3B, respectively).  However, there was no apparent change 
between the CRP-DNA sample and the CRP-LsrR-DNA sample (lanes 4 and 5 in 
Figure 2-3B, respectively), implying no CRP facilitation of LsrR binding to DNA. 
 
 
Figure 2-3.  EMSA with LsrR and CRP. 
(A) Nucleic acid stain of EMSA with increasing amounts of LsrR showing no visible 
shift in bands.  (B)  Nucleic acid and protein stain of EMSA.  Shift of DNA in lane 4 
confirms in vitro activity of CRP.  Lack of variation between lanes 4 and 5 indicates 
no apparent affect of CRP on LsrR activity.  Protein concentrations in (B) are: LsrR - 











1         2         3 
1: LsrR only 
2: DNA only 
3: DNA+100µM LsrR 
4: DNA+10µM CRP 
5: DNA+10µM CRP 
    +100µM LsrR 
1          2          3          4         5 
1: DNA only 
2: DNA+10µM LsrR 





The current model of transcriptional regulation in the lsr regulon incorporates CRP as 
an activator and LsrR as the single repressor of expression [27, 44].  CRP is a well-
characterized activator in E. coli, functioning by binding in upstream promoter 
regions and subsequently recruiting RNA polymerase holoenzyme (RNAP), resulting 
in transcription initiation [27, 71-73].  Although two CRP binding sites have been 
identified in the lsr intergenic region, the sites do not share the same consensus 
sequence and no study has examined CRP binding affinity to these motifs or used in 
vitro binding assays to search for additional sites in the region.   
 Additionally, the implications of LsrR as the single point of relief of lsr 
transcriptional repression during the QS process demonstrate the importance of 
understanding the regulator and its specific function [18, 19, 44].  At the time of this 
writing, however, the binding sites for LsrR in the lsr regulon are still undefined, and 
LsrR activity in vitro is elusive.  In this study we examined CRP binding to the lsr 
intergenic region, its affinity for the two previously identified binding sites, and 
searched for additional sites that may contribute to control of the lsr regulon.  We also 
constructed and purified a His-tagged LsrR in order to assess activity in vitro in an 
effort to define its consensus motif and precise binding location in the lsr region.   
 In vitro analysis of CRP binding using the segmented lsr intergenic region 
(Figure 2-1) validated the two previously identified binding sites and confirmed that 
only two CRP sites exist in this region.  Additionally, the EMSA results show a 
similar magnitude in DNA shift from CRP site I to II, indicating a similar affinity to 




-91 and -68 from the lsrA and lsrR start sites, respectively, and the similar binding 
affinity to each site suggest that transcription in each direction is effectively a 
separate CRP-dependent promoter [60, 74].  However, each CRP protein while bound 
has the potential for affecting distal RNAP binding due to DNA bending and 
conformation and classification as a type I (single point of interaction between RNAP 
and one CRP protein), II (two points of interaction between RNAP and one CRP 
protein), or III (two points of interaction between RNAP and two CRP proteins) CRP-
dependent region can only be determined through individual site mutation and 
expression analysis [60, 75, 76].  CRP analysis and classification in the lsr regulon is 
discussed further in Chapter 4.   
 The purification process for LsrR displayed a striking loss in recoverable 
protein, partially during the washing process but more obviously due to the majority 
of LsrR remaining in the insoluble inclusion body.  Protein insolubility is the focus of 
a staggering number of published studies, and causes of insolubility may include 
protein surface charge, size, rate of formation, or unfavorable features of three 
dimensional structure, among others [77-80].   
 While the recoverable portion of LsrR did not show detectable activity in vitro 
it is possible that the most active protein is also hydrophobic, resulting in the apparent 
lack of DNA binding during EMSA analysis.  Multiple modifications to protein 
growth were attempted in order to improve soluble LsrR yields.  These include 
lowering growth temperature in order to slow misfolding, reducing protein induction 
rates, growth in E. coli strains which enhance disulfide bond formation (hence 




protein production, resuspension of eluted LsrR in buffers with varying pH in order to 
increase stability, and denaturing and refolding of LsrR that had precipitated into the 
inclusion body.  However, none of these approaches yielded significant increases in 
protein yield or activity (data not shown).   
 In order to progress with understanding LsrR characteristics and refining the 
repressor for in vitro use, we searched protein secondary structure databases NCBI 
(http://www.ncbi.nlm.nih.gov) and UniProt (http://www.uniprot.org/) for homologous 
proteins.  LsrR is a member of the SorC family of transcriptional regulators, which 
feature a putative sugar binding domain and an N-terminus helix-turn-helix DNA-
binding domain.  DeoR, also in the SorC family, regulates transcription in vivo as a 
tetramer, binding to at least two operator sites simultaneously and holding the 
upstream region of DNA in a looped state [67, 68, 81, 82].  Similar multimeric form 
and multiple binding site activity are found in other regulators in the SorC family as 
well [69, 83, 84].   
In conclusion, if LsrR has a DNA-binding domain proximal to the N-terminus 
his-tag encoded by pET200LsrR, the tag may interfere with DNA binding activity in 
vitro and prevent the shift of DNA during EMSA.  While unusual, his-tag 
interference has been shown to affect protein activity previously [85].  Analysis of 
LsrR with an oppositely located C-terminus his-tag and resulting activity are further 
described in Chapter 3.  The analysis of the CRP sites in the lsr intergenic region has 
also confirmed the presence of two binding locations having similar affinity.  Various 
models for CRP activation include not only the recruitment of RNAP, but in cases of 




Also, in some cases CRP can bind near to and overlapping the transcription start site, 
acting effectively as a repressor of transcription [90, 91].  The distinct impact of each 

























Chapter 3: Genomic binding site analysis of the AI-2 quorum 
sensing regulator LsrR in Escherichia coli 
 
3.1 Abstract 
The quorum sensing (QS) process evokes significant phenotypic changes among 
multiple species of bacteria as a response to the ‘universal’ signal molecule 
autoinducer-2 (AI-2).  Recent studies in S. typhimurium, V. harveyi, and E. coli have 
shown high conservation of the LuxS-regulated (lsr) set of genes which are expressed 
divergently as a direct result of phospho-AI-2 antagonizing the QS repressor LsrR.  
Given the widespread impact of QS on bacterial genetic expression, we used 
chromatin immunoprecipitation in conjunction with microarrays (ChIP-Chip) to 
discover genomic binding sites for LsrR.  Our results show four putative binding 
locations: lsrR-lsrA, yegE-udk, mppA and yihF.  Of these genes or gene sets, only 
yihF has not been characterized and would not logically be associated with the QS 
response.  Also, because of the apparently unique role of LsrR in repressing the 
divergent lsr regulon, we used reporter plasmids with bidirectional promoter 
segments to further examine expression using β-galactosidase assays.  We report for 
the first time a natural expression bias, independent of LsrR repression, of the AI-2 








The term quorum sensing (QS) is used to define the communication mechanism in 
bacteria which uses chemical signal molecules called autoinducers to induce distinct 
genetic and physiological changes as a response to local population density [5, 29, 
33].  Several QS systems have been identified within distinct bacterial populations 
that mediate intraspecies communication and are characterized by signaling 
molecules such as acyl-homoserine lactones or oligopeptides [92, 93].  Autoinducer-2 
(AI-2) based QS prompts population-dependent genetic changes between many 
species of both Gram-positive and Gram-negative bacteria indicating its potential as a 
‘universal’ bacterial communication system [8].  Supernatant from mid-exponential 
cell culture of Salmonella typhimurium was first documented to generate a QS 
response in Vibrio harveyi [14, 16]; since then, AI-2-dependent QS genes have been 
identified in more than 70 bacterial species and the QS signal molecule is now linked 
to multiple phenotypic changes including virulence, motility, sporulation and biofilm 
formation [8, 20, 29, 94].   
 In E. coli, the enzymatic synthesis steps of AI-2 include the metabolic 
conversion of S-adenosylmethionine (SAM) to S-adenosylhomocysteine (SAH) and 
then S-ribosylhomocysteine (SRH) via the enzyme Pfs.  SRH then interacts with 
LuxS to form the precursor 4,5-dihydroxy-2,3-pentanedione (DPD) which 
spontaneously cyclizes to form two epimeric furanoses, (2R,4S)- and (2S,4S)-2,4-
dihydroxy-2-methyldihydrofuran-3-one (R- and S-DHMF, respectively) [44]. After 
synthesis AI-2 is secreted from the cell via a putative exporter and accumulates in the 




back into the cell via the lsr (LuxS-regulated) ATP binding cassette transporter, 
LsrACDB, and is phosphorylated by the kinase, LsrK.  The resulting phospho-AI-2 
complex purportedly antagonizes the lsr repressor protein LsrR, de-repressing 
transcription of the lsr operon and is further processed by LsrFG in order to prevent 
excess intracellular accumulation of the signal molecule [19].   
 Genes involved in QS are highly conserved, and exploration of the QS 
systems in S. typhimurium, V. harveyi, and E. coli are demonstrating functional 
similarities between species as well [5, 6, 96, 97].  The exact function of the lsr 
operon genes as well as the divergently transcribed repressor lsrR and kinase lsrK 
continue to be elucidated; recent work has described the phosphorylation kinetics of 
AI-2 with LsrK and the affinity of the product of this reaction with LsrR as well as 
AI-2 quorum quenching between populations via extracellular phosphorylation and 
subsequent reduction of the QS response due to bacterial inability to transport 
phospho-AI-2 [12, 44]. 
While DNA binding sites and in vitro LsrR-DNA binding activity have been 
reported in S. typhimurium and effects of its deletion on gene expression in E. coli 
have been revealed, the extent to which LsrR serves as a direct transcriptional 
regulator in the QS regulon has not been fully elucidated [21, 22].  Although in 
various bacterial species the genetic impact of the QS process appears to be 
considerable, specific binding site analysis for LsrR in S. typhimurium using 
chromatin immunoprecipitation in conjunction with microarrays (ChIP-Chip) showed 
only one binding location positively controlled by the QS repressor [49].  In this 




in E. coli MG1655 as a basis for comparison of other bacterial strains utilizing AI-2 
QS.  We also examine LsrR activity in the lsrA-lsrR divergent promoter region and 
measure its direct effect on expression levels using β-galactosidase activity assays.  
Finally, we more closely examine the lsr intergenic region and divergent expression 
effects of LsrR and promoter bias. 
 
 
3.3 Materials and Methods 
 
Bacterial strains, plasmids, and growth conditions.  E. coli strains used in this 
work are described in Table 3-1.  Cultures were grown aerobically at 37°C in Luria-
Bertani (LB) medium to OD 0.35 and supplemented with 1mM IPTG.  Cells used in 
microarray experiments were harvested at mid-exponential (OD 0.8) and stationary 
(OD 1.5) phases.  Media were supplemented as necessary with antibiotics at the 
following concentrations: ampicillin, 50µg ml
-1
; kanamycin, 50 µg ml
-1
; 




Plasmid construction.  Plasmids and primers used in this study are listed in Table 3-
1.  Chromosomal DNA was purified from E. coli MG1655 (DNeasy tissue kit, 
Qiagen, CA, US) and used as the template for all PCR reactions.  For pTH2lsrR, lsrR 
was amplified by PCR using oligonucleotide primers th2lsrRF and th2lsrRR.   The 
PCR product and pTrcHis2 vector (Invitrogen, CA, US) were digested with BamHI 
and HindIII and purified (QIAquick PCR purification kit, Qiagen).  Samples were 




competent cells (Invitrogen) and spread onto LB-agar plates with ampicillin.   
pLsrR26 and pLsrA14 were constructed by amplification of the lsr intergenic region 
(-262 to +12 relative to the lsrR start site) using lsrRP26F/ lsrRP26R and 
lsrAP14F/lsrAP14R, respectively, and digesting the resulting PCR product with 
BamHI and EcoRI.  Plasmid pFZY1, a low-copy mini-F derivative with MCS 
upstream of a promoterless galK'-lacZYA reporter segment [98] was also digested 
with BamHI and EcoRI and purified (Gel Purification Kit, Qiagen).  Ligation and 
selections were performed as described above.  All plasmids were validated by DNA 
sequencing, performed at the DNA Core Facility of the Institute for Bioscience and 





Table 3-1.  E. coli strains, plasmids and oligonucleotides used in this study. 
 
Name Description or Sequence Source 
   
K12 Strains   
   MG1655 Wild type Lab stock 
   CB11 MG1655 ∆lsrR::Cm This study 
   CB13  MG1655 ∆lsrR∆lsrK::Cm, Kan This study 
   
Plasmid   
   pTHlsrR pTrcHis (Invitrogen) derivative, (N-terminus His-tag) containing lsrR, Ap
r
  This study 
   pTH2lsrR pTrcHis2 (Invitrogen) derivative, (C-terminus His-tag) containing lsrR, Ap
r
 This study 
   pFZY1 galK'-lacZYA transcriptional fusion vector, Ap
r
 [98] 
   pLsrA14 pFZY1 derivative, containing lsr intergenic region expressed in direction of lsrA, Ap
r
 This study 
   pLsrR26 pFZY1 derivative, containing lsr intergenic region expressed in direction of lsrR, Ap
r
 This study 
   
Oligonucleotides  
   th2lsrRF TTTGGATCCATGACAATCAACGATTCGGCAATTTCAG This study 
   th2lsrRR TTTAAGCTTTTAACTACGTAAAATCGCCGCTGCTGTGTC This study 
   lsrRP26F TCCGAATTCTCACTCGTTTGCATATTTCCCCC This study 
   lsrRP26R CTCGGATCCCGTTGATTGTCATAATTCATTCTTCACT This study 
   lsrAP14F TCCGAATTCTCGTTGATTGTCATAATTCATTCTTCAC This study 
   lsrAP14R CTCGGATCCTCACTCGTTTGCATATTTCCCC This study 
   yegEPF AATGGATCCGATAATGACGCACTGATGAGACTGATCAGTCAT This study 
   yegEPR TTTGTCGACGGCAATTAATACATGCTGTGATTGTTTGCTCAT This study 
   udkPF AATGGATCCGGCAATTAATACATGCTGTGATTGTTTGCTCAT This study 
   udkPR TTTGTCGACGATAATGACGCACTGATGAGACTGATCAGTCAT This study 
   lsrRHP1 ATCAACGATTCGGCAATTTCAGAACAGGGAATGTGTGTAGGCTGGAGCTGCTT [27] 
   lsrRHP2 GTAACCAGTGCGTTGATATAACCGCCTTTCATTGCATATGAATATCCTCCTTAG [27] 
   lsrKHP1 AGGCATTGTTTTATATAACAATGAAGGAACACCGTGTAGGCTGGAGCTGCTTC [27] 
   lsrKHP2 TCCGCCTGCAAAGACTAACGATGAAGGATGAATAGTCGAATTCCGGGGATCCG [27] 









Chromosomal deletions of lsrR and lsrK.  E. coli strains, plasmids, and 
oligonucleotides used in this study are listed in Table 3-1.  The one-step replacement 
method described by Datsenko and Wanner was used to construct CB13 (E. coli 
MG1655∆lsrR 0lsrK). The phage Red recombination system was first used to 
construct CB11 (E. coli MG1655∆lsrR) by replacing lsrR with an lsrR::cat PCR 
fragment.  PCR fragments were amplified using lsrRHP1 and lsrRHP2 using pKD3 as 
template.  The PCR products were purified, incubated with DpnI and introduced by 
electroporation into E. coli MG1655 bearing the Red recombinase helper plasmid 
pKD46.  Recombinants were incubated at 37°C and selected on LB-agar 
supplemented with chloramphenicol.  Colonies were grown at 37°C to cure the Red 
recombinase plasmid and the cat insert was verified by PCR.  Once verified, pKD46 
was re-introduced into CB11 and the phage Red system was repeated in order to 
replace lsrK with an lsrK::kan segment generated by PCR with primers lsrKHP1 and 
lsrKHP2 and template plasmid pKD13.  After selection on LB-agar plates 
supplemented with chloramphenicol and kanamycin and curing of the Red 
recombinase plasmid, the deletion of both lsrR and lsrK was verified by PCR tests. 
 
Chromatin immunoprecipitation.  E. coli strain CB13 was transformed with 
pTH2lsrR and grown as previously described.  Chromatin immunoprecipitation 
(ChIP) was conducted as previously described[99] with some variations.  Briefly, 1L 
cells were grown to desired OD and cross-linked with 1% freshly prepared 
formaldehyde for 25 minutes at room temperature, after which 125mM glycine was 



















Figure 3-1.  ChIP-Chip process. 
(A) Cells are grown under desired conditions and fixed with formaldehyde, covalently 
binding DNA to proteins.  (B) Cells are lysed and lysate is sonicated, shearing DNA (with 
proteins attached) into 300-1000 bp segments (C).  (D) Protein-DNA complexes are 
precipitated using Protein G-coated magnetic beads with anti-histidine antibody.  (E) IP is 
processed to remove beads, antibody, and protein of interest, resulting in DNA segments 






















centrifugation and washed twice with 50 mL ice-cold TBS.  Washed cells were 
resuspended in 5 mL IP buffer composed of 20mM Tris (pH 7.4), 200mM KCl, 1mM 
EDTA, protease inhibitor cocktail (Sigma-Aldrich, St. Louis, MO, US).  Cell 
suspension was separated into 1 mL aliquots and sonicated 4 x 20 seconds on ice in 
order to lyse cells and shear chromatin to an average size of 500-600 bp (see Section 
3.6, Supplemental Data).  Cell debris was separated by centrifugation at 20,000 rcf 
for 15 minutes at 4°C and supernatant was combined.  To immunoprecipitate LsrR-
DNA complexes, ChIP-grade 6x His tag antibodies (Abcam, Cambridge, MA, US) 
were added and incubated overnight at 4°C on a rotator.  Two separate mock-IPs 
were conducted under the same conditions using anti-rabbit IgG antibody and sterile 
Rabbit serum (Abcam).  50µl of Protein G magnetic beads (Thermo-Fisher, Rockford, 
IL, US) was added to each solution and rotated for 4 hours at 4°C, after which the 
beads were washed and protein-DNA complexes were eluted and purified as 
previously described [50].  Five biological replicate positive chromatin-IP and mock-
IP samples were collected and used for array hybridization. 
 
Quantitative PCR.  Differences in quantity of immunoprecipitated versus mock-IP 
DNA were measured by qPCR using a SmartCycler System (Cepheid, Sunnyvale, 
CA, US) and iQ SYBR Green Supermix (Bio-Rad).  All samples were evaluated in 
triplicate, and threshold cycle (Ct) values were calculated using SmartCycler 2.0 
software.  Ct values were normalized between samples using three random sites 
inside coding regions in the E. coli genome as the reference set against which two 




D0A amplification, labeling and microarray hybridization.  IP (test) and mock-IP 
(background) samples were amplified using a GenomePlex Whole Genome 
Amplification (WGA2) Kit (Sigma-Aldrich) and purified using QIAquick PCR 
purification kit (Qiagen).  Test and background samples were then labeled and 
hybridized onto E. coli K12 MG1655 whole genome tiling arrays following 
manufacturer protocols (Nimblegen, Madison, WI, US).  Arrays were scanned with a 
G2505C DNA microarray scanner at 2 micron resolution (Agilent, Santa Clara, CA, 
US).  Arrays were repeated five times using replicate immunoprecipitation sets as 
previously discussed.   
 
Data Analysis.  Array data were processed using Nimblescan v2.4 software and 
visualized on SignalMap v1.9 (Nimblegen).  Peak locations were selected using a 
false discovery rate (FDR) of 0.01 resulting in a 99% probability of valid binding site 
identification.  Additionally, to further increase accuracy of binding site locations and 
to eliminate false positives due to background, peak data were manually evaluated 
based upon log2 value, width, shape, and location relative to transcriptional start site.  
Peaks that were not within the theoretical width estimate of 500-2500 bp, displayed 
erratic or noisy curve shape, or showed less than 4-fold enrichment over mock-IP 
were disregarded.   
 
β-galactosidase activity assays.  To determine the effect of LsrR on expression 
levels, pFZY1-derived plasmids (Table 3-1) were transformed into both E. coli 




appropriate antibiotic, diluted 100-fold into fresh media, and grown to mid-
exponential phase (OD 0.8).  To determine β-galactosidase activity cells were 
processed in triplicate in 96-well microplates as previously described[40].  A420, A550 
and A600 values were collected on a Synergy HT Multi-Mode microplate reader 
(Biotek Instruments, VT, US).   
 
Computer Modeling of LsrR 
Secondary structure analysis for LsrR from E. coli K12MG1655 was retrieved from 
UniProt[100]. The amino acid sequence for K12MG1655 (NCBI Gene ID: 946070) 
was submitted to the I-TASSER tertiary protein structure prediction server, Center for 
Computational Medicine and Bioinformatics at the University of Michigan 
(http://zhanglab.ccmb.med.umich.edu/I-TASSER).  The resulting data were further 





LsrR shows limited binding throughout E. coli K12 MG1655 genome.  Initial 
experiments with pTHlsrR (N-terminus His-tagged LsrR construct) yielded low 
quantities of purified protein and poor in vivo immunoprecipitation results (Figure 3-
1A,C).  A common challenge with DNA-binding proteins, we found the majority 
(>95%) of overproduced LsrR remained in inclusion bodies during expression and 
purification; denaturing and refolding LsrR did not improve in vitro activity (data not 













Figure 3-2.  Purification and computer modeling analysis of LsrR in E. coli.   
Recombinant LsrR was constructed by inserting lsrR from K12MG1655 into separate 
vector encoding an N-terminus or C-terminus His-tag and and purified using Ni-NTA 
beads.  (A) Parallel protein purification eluates of each recombinant LsrR and PAGE 
analysis using 0.1µl, 1µl, and 10µl aliquots show significantly higher yields of LsrR 
with the C-terminus His-tag.  (B) Computer modeling and tertiary structure analysis 
of LsrR revealed the putative helix-turn-helix DNA-binding site (region I) and sugar 
binding domain (region II).  The close proximity of the N-terminus His-tag 
(immediately adjacent to AA1) to DNA-binding site I indicates possible 
inaccessibility of the His-tag during DNA binding.  (C) qPCR results of 
immunoprecipitation of lsr intergenic DNA for C-terminus and N-terminus His-
tagged LsrR versus randomly selected negative controls ydiV, yjeP, and ftsQ.  Values 
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indicate two likely DNA binding regions (Figure 3-1B).  Region I, identified by I-
TASSER as a likely helix-turn-helix DNA binding region, is directly adjacent to the 
N-terminus His-tag encoded by pTHlsrR.  Region II, closer to the C-terminus for 
LsrR, is a predicted ligand binding site, and is a structural analog to the effector 
binding domain for members of the SorC family of transcriptional regulators.  Given 
the difficulty of purifying the N-terminus His-tagged LsrR and the poor 
immunoprecipitation results as well as the proximity of the His-tag to binding region 
I, a high-copy inducible vector encoding a C-terminus 6xHis-tag encoding lsrR was 
constructed and provided much better results with immunoprecipitation in vivo as 
well as significant increases in purified protein (Figure 3-1A,C); however, in vitro 
activity was still undetectable when purified recombinant LsrR was used in 
electrophoretic mobility shift assays (EMSA) (data not shown). 
 Increased yields of DNA during immunoprecipitation with the C-terminus 
His-LsrR permitted ChIP-Chip in conjunction with Nimblegen microarrays to be used 
for determining direct LsrR binding sites.  Figure 3-1C depicts quantitative PCR 
results demonstrating the relative amounts of lsr intergenic DNA present after 
immunoprecipitation using C-terminus and N-terminus his-tagged LsrR as compared 
to randomly selected negative control regions in ydiV, yjePI, and ftsQ.  Relative 
enrichment values clearly show an increased capacity for DNA binding and capture 
using the C-terminus LsrR.  Microarray data indicate two putative binding sites for 
LsrR with at least 8-fold enrichment over mock-IP DNA, the lsrR-lsrA and  yegE-udk 
intergenic regions, as well as two other sites with at least 4-fold enrichment, mppA 




binding regions are localized at the approximate center of the normal bell-shaped 
distribution of ratios.   
Each distribution consists of microarray probes representing 50-bp, 
overlapping sections of the E. coli K12MG1655 genome and curve shapes represent 
binding of immunoprecipitation products of 500-1000 bps.  The ChIP-Chip process 
and peak curve analysis were further described by Waldminghaus and Skarstad [50].  
The artifact in Figure 3-2B showing a sharp drop in enrichment ratio on the left of the 
distribution is a result of the deletion of lsrR.  Quantitative PCR was used to validate 
array data after immunoprecipitation using two sets of primers corresponding to the 
indicated binding region and three additional sets matching random sites in the E. coli 
genome.  Figure 3-2F shows relative quantities of DNA present after 
immunoprecipitation indicating increased levels of precipitated DNA fragments 
corresponding to indicated LsrR binding sites lsrA-lsrR, yegE-udk, mppA, and yihF 
(black bars) as compared to negative controls (white bars).  Next, ChIP-Chip data 
were manually evaluated for peak magnitude, curve shape, and width.  Peaks that did 
not fall within the theoretical width projection of 500-2500 bp, displayed erratic or 
noisy curve shape, or showed less than 4-fold enrichment over mock-IP were 




















Figure 3-3.  ChIP-Chip in E. coli K12MG1655.  
Genomic distribution (A) and localized probe ratios (B-E) of putative LsrR binding 
regions.  Annotated bars below localized sections display regional gene locations with 
direct and complementary genes located above and below the mid-line, respectively.  
Peak values represent the log2 ratio of control vs. mock-IP DNA for each individual 
probe.  See discussion for more details.  (F) qPCR comparison of ChIP product 
measuring indicated peak regions (black) compared to randomly selected negative 
controls (white) showing significantly greater precipitation of lsr intergenic DNA 
using the C-terminus his-tagged LsrR when compared to the N-terminus his-tagged 
LsrR and randomly selected negative controls ydiV, yjeP, and ftsQ.  Values represent 























































































































































































































































































Transcriptional expression bias exists towards the lsr operon.  Our ChIP-Chip 
data indicate that LsrR has several putative regulatory sites throughout the E. coli 
genome; however, in order to begin examining these novel sites more understanding 
about specific LsrR regulatory activity is required.  The divergent structure of lsr 
regulon adds complexity when examining LsrR activity and while the effect of LsrR 
on expression levels in both directions has been previously measured [20, 27], 
promoter effects independent of LsrR have not been shown.  To further explore 
directionality in the lsr intergenic region, we isolated and inserted the promoter 
segment in opposite directions into pFZY1 plasmids to evaluate the effect of LsrR on 
expression of lacZ in wild-type E. coli K12MG1655 and the lsrR mutant (CB11) 
using β-galactosidase reporter assays (Figure 3-3A).   
 Growth curves (OD600) and lacZ expression levels using pLsrA14 and 
pLsrR26 in WT and CB11 strains are shown in Figure 3-3B and indicate obvious 
repression effects of LsrR were in both directions (cross hatched bars).  These 
variations are further illustrated in Figures 3-3C and 3-3D.  As expected, QS gene 
expression is observed to be switched on in the late exponential phase.  In Figure 3-
3C the effects of LsrR derepression result in an up to 5.5-fold increase in expression 
in CB11.      
 Also, it was apparent that either with or without the presence of LsrR, gene 
expression in the direction of lsrA was always greater than that in the direction of 
lsrR. We refer to this as promoter bias in the direction of lsrA.  Figure 3-3D illustrates 
this difference in expression levels in the direction of lsrA (pLsrA14) versus lsrR 













Figure 3-4.  Promoter region orientation and directional expression analysis of 
the E. coli lsrA-lsrR intergenic region.   
The E. coli K12MG1655 intergenic region (from -262 to +12 relative to the lsrR start 
site) between lsrA and lsrR was inserted in opposite directions into the MCS of the 
low-copy mini-F derivative pFZY1.  (A) pLsrA14 and pLsrR26 express lacZ using 
the lsr promoter region oriented toward lsrA and lsrR, respectively.  (B) E. coli strains 
K12MG1655 wild-type (WT) and K12MG1655∆lsrR (CB11) each carrying lacZ 
expression plasmids pLsrA14 and pLsrR26.  Cultures were grown at 37°C in LB and 
samples were collected at time points shown from 0-10 hours and overnight for 
measuring cell density (connected lines) and β-galactosidase activity (bars).  (C) Fold 
increase in expression levels in an lsrR mutant using pLsrA14 (triangles) and 
pLsrR26 (squares).  Point values represent average expression difference between 
CB11 and WT strains for each time point (±5% error).  (D)  Fold increase in 















































































































































































































































































































































greater expression towards lsrA in early exponential growth (4 hours) to 1.6-fold 
greater during stationary phase (overnight).  The trend showing a steadily growing 
difference in expression of pLsrA14 versus pLsrR26 in both the WT and lsrR 
indicates that the expression bias toward lsrA is inherent to the lsr intergenic region 
and is not influenced by LsrR.   
 
3.5 Discussion 
In this study we investigated genomic binding sites for LsrR, as well as divergent 
transcriptional activity within the lsr regulon.  Although some investigation has been 
performed on the binding activity and expression results of LsrR in E. coli [22, 27], 
very little is known about the molecular kinetics of the QS regulator such as exact 
binding cues, interactions with secondary proteins or activators, or even whether it 
exists and functions in monomeric or multimeric form in vivo.  This may be 
demonstrated by the greatly reduced purification and in vivo activity found with an N-
terminus as compared to C-terminus His-LsrR (Figure 3-1A,C) and our subsequent 
difficulty with in vitro EMSA.  While LsrR was shown to be antagonized by the 
phosphorylated AI-2 molecule [22, 27] and extracellular AI-2 phosphorylation 
reduced the QS response [12], the exact DNA binding cue for the QS regulator has 
not yet been determined and LsrR activation may be based upon secondary protein 
interactions, unphosphorylated AI-2 availability [21], or other activators [19, 27, 
101].   
lsrR belongs to the sorC transcriptional regulatory family which has an N-




binding domain [100, 102].  In addition, both SorC and DeoR, another transcriptional 
regulator with structural similarities to LsrR, are biologically active in tetrameric 
form with DNA binding domains which extend divergently from the center, 
suggesting operator binding in at least two distinct regions [53, 66, 103, 104].  Recent 
crystallographic analysis indicated the presence of two molecules per asymmetric unit 
for LsrR, and quaternary structure for DNA-binding proteins with helix-turn-helix 
domains is common [52, 66].  However, given the domain similarities to the sorC 
family and the concentration-dependent transition from dimer to tetramer states noted 
during crystallography [54, 105], it is probable that LsrR is not only activated prior to 
binding DNA but functions in vivo as a tetramer.  Still, further work is needed to 
confirm the in vivo structure and binding kinetics of the QS regulator.   
The ChIP-Chip process is inherently vulnerable to background noise, 
generating false-positive or false-negative peaks as a result of several factors 
including non-specific antibody binding, incomplete reversion of crosslinks, or 
insufficient RNase treatment, among others [50].  To maximize signal-to-noise ratios, 
ChIP protocols used here were identical for both the test and background samples, 
differing only in the type of antibody added, and both samples were amplified using 
whole genome amplification (WGA).  This method reduces error due to non-specific 
antibody-protein binding, which we found to be the major contributor to false-
positive microarray results, as well as reduces potential loci amplification bias.  Also, 
LsrR is antagonized by phospho-AI-2, causing the regulator to unbind DNA [22, 27, 
44].  Clearly having the potential to affect ChIP by reducing LsrR binding 




the AI-2 kinase, lsrK.  Additionally, in order to remove the possibility of native LsrR 
outcompeting the His-tagged LsrR in vivo, we also mutated lsrR in K12MG1655. 
While the lsr intergenic region has been documented for direct LsrR binding 
and regulation in E. coli [19, 22, 27], the three other putative LsrR binding sites 
indicated in Figure 2A have not been shown.  The uridine/cytidine kinase udk and the 
predicted diguanylate cyclase yegE (Figure 2C) are also expressed from a divergent 
promoter similar to that found in the lsr region.  In E. coli, udk mutants were shown 
to accumulate the endogenous inducer cytidine, while yegE has been directly linked 
to the transition from motility to sessile behavior [36, 106, 107].  Studies have clearly 
shown the linkage of the QS response to biofilm formation and motility [21, 37, 94, 
108] and given the metabolic and phenotypic implications of the udk-yegE divergent 
gene set, it is feasible that they are regulated in conjunction with the bacterial QS 
system through LsrR.  In order to build an exact DNA binding motif for LsrR we 
compared the lsr and udk-yegE intergenic regions using MEME motif discovery tool 
and previously indicated LsrR binding sites [22, 109]; while attractive hypotheses for 
binding locations could be made, given the limited sample size and lack of apparent 
motif homology we could not consider similarities significant (data not shown).  
The murein tripeptide transporter subunit mppA also has potential linkage to 
the QS system due to its functional binding to heme, a primary iron source for Gram-
negative bacteria [110, 111].  During the process of infection, iron levels are directly 
connected to formation, and possibly regulation, of virulence factors and toxins in 
bacteria [112, 113] and pathogenicity has also been directly linked to the QS process 




yihF, requires further functional analysis in order to evaluate its potential role in the 
QS process.  Although mppA and yihF yielded lower relative enrichment versus 
mock-IP than the lsrA-lsrR and udk-yegE regions, the lack of data regarding exact 
LsrR binding activators, potential co-regulators or in vivo form preclude the mppA 
and yihF sites from being disregarded.  Therefore, these regions await additional 
study to confirm direct LsrR regulation.  
 A more complete understanding of the regulatory effect of LsrR and structure 
of the complex lsr regulon would greatly contribute to further examination of the 
additional putative LsrR regulatory sites indicated during ChIP-Chip.  Therefore, we 
focused on divergent expression in the lsr regulon examining the effect of LsrR as 
well as promoter strength in the intergenic region.  Previous studies of LsrR from E. 
coli indicate potential binding sites for the regulator in the lsr operon [22] and were 
shown in vivo to have a direct effect on expression of the lsr operon under normal 
conditions [27].  In order to further analyze in vivo LsrR binding and regulation in the 
lsr intergenic region, we used β-galactosidase activity assays with reporter plasmids 
containing the lsr intergenic promoter region, oriented in opposite directions, in E. 
coli K12MG1655 and K12MG1655∆lsrR (CB11) (Figure 3-3A).  Our results indicate 
that LsrR has a comparable bi-directional regulatory effect in the lsr regulon (Figure 
3-3C).  That is, LsrR regulates expression in both the lsrA and lsrR directions by 
direct interaction with the lsr intergenic region, and has similar impact on divergent 
expression regardless of promoter strength.   
However, we also noted that the intergenic promoter region yielded an 




demonstrates the steadily increasing expression level differences when using 
pLsrA14 and pLsrR26 in both the WT and CB11 strains.  This relative linearity in 
percent increase of expression suggests a stronger innate promoter region for lsrA 
than for lsrR, but similar increases in expression measured in both WT and CB11 
strains indicate that LsrR binding and repression is not affected by the stronger 
promoter.  The natural bias also indicates that the AI-2 transport protein LsrACDB 
may be more available intracellularly than LsrR throughout the cell cycle providing 
an early and constant supply of AI-2 and increased sensitivity to exogenous AI-2.  
Also, we postulate that the AI-2 kinase lsrK, which is immediately downstream of 
lsrR, is either expressed at a lower level than the lsr operon and is still metabolically 
effective, is a limiting factor in the phosphorylation of available AI-2 and therefore 
essentially a QS regulator itself, or has its own promoter as previously suggested [20] 
and is unaffected by the lsr intergenic directional bias.  Our current work is exploring 
further the binding dynamics of the QS repressor LsrR in this operon.   
 In summary, we have shown that while QS in bacteria has widespread genetic 
and phenotypic implications, LsrR in E. coli MG1655 appears under normal 
conditions to directly associate with only four binding sites.  However, three of these 
indicated sites, lsrR-lsrACDBFG, yegE-udk, and mppA have direct potential ties to 
the QS process and require further analysis.  Since genomic binding analysis assays 
such as ChIP-Chip or ChIP-Seq are dependent upon multiple preparatory factors 
which may introduce error into the resulting data including fixation, DNA shearing, 
antibody specificity, and non-specific binding, we maintain that there may be other 




data, but might also be sufficiently transient or weak to provide positive identification 
using the tools as described here.  That is, given the dynamic nature of bacterial QS, 
numerous possible internal and environmental cues may affect the lsr system and 
subsequently LsrR binding events.  These considerations, therefore, lead us to use 
these results as primary indicators of regions in which to begin further analysis.  Our 
current efforts continue work on binding specificity and activity for LsrR in the lsr 






3.6 Supplemental Data 
Chromatin Shearing and Whole Genome Amplification (WGA).  The ideal size 
for sheared chromatin to be applied to microarrays for ChIP-Chip analysis is 400-
1000 bp [50, 58, 59].  Excessive shearing may cause protein-DNA dissociation, DNA 
over-fragmentation, or denaturing, and under-fragmentation will yield fragments too 
large for the amplification process [50].  In order to ensure our samples were within 
the ideal size range and usable for proper hybridization, various cultures of E. coli 
K12 MG1655 were grown to stationary phase and harvested via centrifugation for 
resuspension and shearing.  Shearing was conducted using a Misonix Microson 
XL2000 sonicator.  Conditions evaluated during sonication were: culture 
resuspension density, culture resuspension volume, time of sonication, and sonication 
intensity.   
 Cultures were resuspended in volumes of resuspension buffer (50 mM Tris-
Cl, pH 8.0, 10 mM EDTA) corresponding to ratios of original culture.  That is, three 
final cell density samples were tested with 1:1000, 1:100 and 1:10 ratios of 
resuspension buffer to original culture volume.  For each sample, 5 ml of solution was 
sonicated for 10x30 seconds in an ice bath at 50% power and DNA was collected 
using a QIAquick PCR purification kit (Qiagen).  Agarose gel analysis shows no 
detectable size difference in DNA between samples with varying cell density (data 
not shown).   
 Resuspended cultures were then separated into 10ml, 5ml, and 1ml samples 
and again sonicated for 10x30 seconds in an ice bath at 50% power.  DNA was again 





















Figure 3-5.  Chromatin shearing.   
(A) 10ml, 5ml, and 1ml samples of resuspended cell culture showing difference in 
shearing of DNA as a result of sample volume.  1ml sample also demonstrates 
overshearing of chromatin sample.  (B)  1 ml samples of resuspended cell culture 
sonicated at 50% power for 10x30, 20x30, and 30x30 seconds.  Sample sonicated for 
20x30s displays best size range without overshearing.  ‘L’ in both Figures is 1kb Plus 
DNA Ladder (Invitrogen).  Band causing loss of image saturation in approximate 














demonstrate significant difference in 1ml sample size versus 5ml and 10ml sets 
(Figure 3-4A), indicating a much greater dependence upon sample volume than 
sample density for shearing effectiveness.  In order to assess sonication time and 
intensity simultaneously, 1 ml samples of resuspended culture were sonicated at 
100% and 50% power for 10x30, 20x30, and 30x30 second pulses.  50% power 
shearing produced DNA fragments that were well above the 1000 bp upper limit and 
were deemed unusable (data not shown).  Samples sheared at 100% power for 20x30 
seconds yielded DNA fragments that were usable for whole genome amplification 
(WGA) (Figure 3-4B). 
Samples sonicated to within the desirable size range for WGA were purified 
using a QIAquick PCR purification kit (Qiagen).  A GenomePlex Whole Genome 
Amplification Kit (WGA2, Sigma) was used with various amounts of E. coli genomic 
DNA in order to determine the ideal starting quantity of DNA for the WGA process.  
1, 10, and 25 ng samples of DNA were isolated, purified, and amplified using the 
WGA2 kit (Figure 3-5).  Agarose gel analysis of purified WGA samples indicates that 
a minimum of 10ng of immunoprecipitated DNA would be necessary for 




























Figure 3-6.  Whole Genome Amplification.   
25ng, 10ng, and 1ng starting quantities of sheared DNA used in WGA process.  
Results indicate a minimum of 10ng of DNA for effective amplification.  ‘L’ is 1kb 
Plus DNA Ladder (Invitrogen). 




Chapter 4: Expression Regulation in the Divergent Quorum 




The quorum sensing (QS) process induces shifts in genetic expression as a response 
to signal molecules termed ‘autoinducers’, queueing diverse phenotypic changes in 
various species of bacteria.  The lsr (LuxS-regulated) regulon is negatively regulated 
by the transcriptional repressor LsrR via a direct response to threshold levels of 
extracellular autoinducer-2 (AI-2).  This autoinducer elicits responses both within and 
between a multitude of bacterial species.   In this study we show that expression in 
both directions of the divergent lsr gene set is dependent upon simultaneous binding 
of two cyclic-AMP receptor proteins (CRP). We also demonstrate that full lsr 
repression occurs via concurrent LsrR binding to opposite ends of the intergenic 
region, implying the formation of a looped DNA complex.  The previously 
unreported potential for high expression of lsrR, the more stringent LsrR regulation of 
lsrR than lsrACDB, and an apparent secondary integration host factor (IHF)-like 





Several quorum sensing (QS) systems have been identified among bacteria which 
serve as communication mechanisms that induce various phenotypic or genetic shifts 
in response to local cell density [5, 29, 33].  These systems include acyl-homoserine 
lactone (AHL) signaling, more common in Gram-negative species, and oligopeptide 
signaling, found in Gram-positive strains, both of which utilize highly species-
specific molecules to draw a population-based response [23, 28, 29, 32].  The 
autoinducer-2 (AI-2) QS system, however, has been noted for its capacity to elicit 
marked responses both within and across species by employing a common synthase, 
LuxS, to form 4,5-dihydroxy-2,3-pentanedione (DPD), the precursor to AI-2 [44].  
While luxS homologs have been identified in at least 55 species, QS genes and their 
functional similarities in model organisms such as V. harveyi, S. typhimurium, and E. 
coli continue to be explored for the exact genetic circuitry and dynamics involved in 
the AI-2 response [6, 9, 20, 34, 44, 97]. 
 In E. coli, AI-2 is produced enzymatically via the methyltransferase 
conversion of S-adenosylmethionine (SAM) to S-adenosylhomocysteine (SAH), 
which then interacts with the nucleosidase Pfs to form S-ribosylhomocysteine (SRH).  
LuxS then converts SRH to DPD, which spontaneously cyclizes forming AI-2 (40, 
47).  Although any one of several specific structures of AI-2 may result, the signal 
molecule interconverts rapidly between equilibrating forms permitting detection by 
various bacteria with homologous QS circuitry [44, 97, 101, 115].  In E. coli QS 
circuitry, AI-2 is synthesized and exported, accumulating extracellulary in proportion 




ATP binding cassette transporter LsrACDB.  After import and phosphorylation by the 
kinase LsrK, AI-2 increases expression of the lsr operon by binding to the QS 
regulator LsrR, derepressing transcription [19, 27, 44].  
 While much focus has been placed upon global impacts of the bacterial QS 
response, mechanistic details of the lsr set of genes remain obscure.   AI-2 transport, 
phosphorylation, and binding to LsrR are well documented in E. coli and S. enterica 
[44] but only recently have a putative DNA binding site motif and in vitro response to 
phospho-AI-2 been described for LsrR [22].  Current models of the QS circuit assign 
LsrR the role as sole transcriptional regulator for both the lsr and lsrRK operons, 
implying a single point of genetic activation during a QS response [18, 27, 116].  
Interestingly, despite the connection of the QS mechanism to responses such as 
bioluminescence [14, 117], virulence [114, 118], motility [119, 120], and biofilm 
formation [38, 42], ChIP-Chip analysis with LsrR in S. typhimurium and E. coli have 
shown unexpectedly few direct binding sites [49].  This may suggest hierarchical 
modes of regulation including complex and transient genetic assemblies that may not 
be revealed in ChIP-Chip assays.  That is, genomic binding assay conditions may 
over- or underrepresent binding activity [50, 59], and understanding the molecular 
basis for the global impact of AI-2 QS warrants further and more detailed 
examination of LsrR regulation.    
In this study, we focus on transcriptional regulation in the divergent promoter 
region of the lsr and lsrRK operons and evaluate the effects of various DNA 
mutations on putative LsrR and cAMP-reactive protein (CRP) binding sites on 




analysis in order to describe LsrR repression.  We assemble our observations in the 
context of similar repressor systems and present a novel model for LsrR regulation 
incorporating CRP, DNA looping, and a secondary layer of repression involving an 
integration host factor (IHF)-like protein as part of the lsr regulatory mechanism. 
 
4.3 Materials and Methods 
Bacterial strains, plasmids, and growth conditions.  All strains and plasmids used 
in this work are described in Table 4-1.  Cultures were grown aerobically at 37°C in 
LB medium to OD 0.8 or as noted.  Media were supplemented with antibiotics at the 
following concentrations: ampicillin, 50µg ml
-1




Plasmid construction.  Plasmids pLsrR26 and pLsrA14 were described previously 
(Byrd et al., submitted for publication) and contain the entire native lsr intergenic 
region (-262 to +12 relative to the lsrR start site) in opposite orientations.  All 
modified promoter segments were designed and submitted for synthesis by IDTDNA 
(IA, US).  Modified sequences were received in pIDTSmart vectors and transformed 
into TOP10 chemically competent cells (Invitrogen, CA, US) for amplification.  After 
purification (QiaPrep Spin Miniprep kit, Qiagen) plasmids were digested with BamHI 
and EcoRI and regions of interest were extracted using agarose gel purification (Gel 
Purification Kit, Qiagen).  pFZY1, a low-copy mini-F derivative with MCS upstream 
of a promoterless galK'-lacZYA reporter segment [98] was also digested with BamHI 
and EcoRI and gel purified.  Ligation and selections were performed using standard 








 Source or Reference 
   
K12 Strains   
   MG1655 Wild type Laboratory stock 
   CB11 MG1655 ∆lsrR::Cm Byrd et al.
b
 




   plsrR26 native lsr intergenic region expressed in direction of lsrR, Ap
r
 Byrd et al.
b
 
   plsrA14 native lsr intergenic region expressed in direction of lsrA, Ap
r
 Byrd et al.
b
 
   pcrp22 mutation of CRP binding site C1, expressed in direction of lsrR, Ap
r
 This study 
   pcrp9 mutation of CRP binding site C1, expressed in direction of lsrA, Ap
r
 This study 
   pcrp23 mutation of CRP binding site C2, expressed in direction of lsrR, Ap
r
 This study 
   pcrp8 mutation of CRP binding site C2, expressed in direction of lsrA, Ap
r
 This study 
   pcrp4b mutation of CRP binding sites C1 and C2, expressed in direction of lsrR, Ap
r
 This study 
   pcrp10 mutation of CRP binding sites C1 and C2, expressed in direction of lsrA, Ap
r
 This study 
   plsrR24 mutation of operator sites O1 and O2, expressed in direction of lsrR, Ap
r
 This study 
   plsrA13 mutation of operator sites O1 and O2, expressed in direction of lsrA, Ap
r
 This study 
   plsrR27 mutation of operator sites O1 and O3, expressed in direction of lsrR, Ap
r
 This study 
   plsrA11b mutation of operator sites O1 and O3, expressed in direction of lsrA, Ap
r
 This study 
   plsrR33 mutation of operator sites O1 and O4, expressed in direction of lsrR, Ap
r
 This study 
   plsrA34 mutation of operator sites O1 and O4, expressed in direction of lsrA, Ap
r
 This study 
   plsrR31 mutation of operator sites O2 and O3, expressed in direction of lsrA, Ap
r
 This study 
   plsrA32 mutation of operator sites O2 and O3, expressed in direction of lsrR, Ap
r
 This study 
   plsrR30 mutation of operator sites O2 and O4, expressed in direction of lsrA, Ap
r
 This study 
   plsrA11 mutation of operator sites O2 and O4, expressed in direction of lsrR, Ap
r
 This study 
   plsrR25 mutation of operator sites O3 and O4, expressed in direction of lsrA, Ap
r
 This study 
   plsrA12 mutation of operator sites O3 and O4, expressed in direction of lsrR, Ap
r
 This study 
   plsrR39 mutation of site P1, expressed in direction of lsrR, Ap
r
 This study 
   plsrA40 mutation of site P1, expressed in direction of lsrA, Ap
r
 This study 
   plsrR37 mutation of site P1 and O1, expressed in direction of lsrR, Ap
r
 This study 
   plsrA38 mutation of site P1 and O1, expressed in direction of lsrA, Ap
r
 This study 
   plsrR35 mutation of site P1 and O3, expressed in direction of lsrR, Ap
r
 This study 
   plsrA36 mutation of site P1 and O3, expressed in direction of lsrA, Ap
r
 This study 
   plsrR41 mutation of site P2, expressed in direction of lsrA, Ap
r
 This study 
   plsrA42 mutation of site P2, expressed in direction of lsrR, Ap
r
 This study 
   plsrR43 mutation of site O2 and P2, expressed in direction of lsrA, Ap
r
 This study 
   plsrA44 mutation of site O2 and P2, expressed in direction of lsrR, Ap
r
 This study 
   plsrR45 mutation of site O3 and P2, expressed in direction of lsrA, Ap
r
 This study 
   plsrA46 mutation of site O3 and P2, expressed in direction of lsrR, Ap
r
 This study 
         
a 
All plasmids are derivatives of the promoterless galK'-lacZYA fusion vector pFZY1.  See Materials and Methods.   
        
b
 C. M. Byrd, C. Y. Tsao, W. M. Bentley, submitted for publication 




DNA Core Facility of the Institute for Bioscience and Biotechnology Research 
(IBBR).  
 
β-galactosidase activity assays.  All pFZY1-derived plasmids (Table 4-1) were 
transformed into both E. coli K12MG1655 and CB11 strains as described previously 
[122].  Cultures of E. coli were grown overnight in LB using appropriate antibiotic, 
diluted 100-fold into fresh media, and grown to mid-exponential phase (OD 0.8).  
Cells were processed in triplicate in 96-well microplates as previously described [40].  
A420, A550 and A600 values were collected on a Synergy HT Multi-Mode microplate 




Both CRP sites are required for full lsr expression.  Two CRP consensus sites 
were previously identified in the lsr intergenic promoter region, and the prevention of 
CRP binding in vivo via the addition of glucose demonstrated a precipitous drop in 
overall expression of the lsr operon [20, 27].  In order to examine the impact of each 
CRP site separately, expression analysis was conducted using reporter plasmids 
containing directionally oriented lsr intergenic promoter regions with mutated CRP 
binding sequences (annotated as C1 and C2 in Figure 4-1A).  Because certain 
repressors, including LsrR, have been shown also to activate gene expression [21, 




K12MG1655 wild-type (WT) and CB11 (∆lsrR) strains in order to determine the 
specific role of the effector, LsrR.   
In Figure 4-1B, we list the specific mutations introduced into each site.  The 
mutant form is indicated above that of the wild type sequence.  In Figure 4-2, we list 
the β-galactosidase expression for each vector in the direction indicated.  For 
example, pcrp9 is a vector containing the lsr intergenic region with the C1 mutation 
as the promoter segment for lacZYA.  The expression levels for pcrp9 measured in the 
direction of lsrA was 6 and 4 MU in the WT and CB11 strains, respectively.  Vector 
pcrp22, containing the same promoter region but oriented in the opposite direction 





Figure 4-1.  Schematic of lsr intergenic region.   
(A) Map of region showing sites selected for mutation analysis.  Sites O1 through O4 
(circles) represent putative LsrR binding regions; C1 and C2 (boxes) are cAMP-CRP 
binding sites; P1 and P2 (hexagons) are negative controls.  (B)  Intergenic region for 
lsr regulon (uppercase letters) showing sequences of sites from (A).  Segments 
located above indicated sites display mutated sequences for that region.  For each 
CRP binding region [27] only consensus sequence (TCACA) was mutated.  Arrows 
represent transcription start sites for divergent gene (lowercase letters).  Points above 
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As expected, mutation of each CRP binding site resulted in a marked drop in 
expression of its corresponding adjacent gene.  Mutation of C1 abolished expression 
of lsrA (by >96%) and mutation of C2 resulted in a similar drop in lsrR expression 
(Figure 4-2).  Incidentally, we found that the CRP mutations also impacted expression 
for those representative genes located oppositely and distally from mutated sites.  
Specifically, the C1 mutation reduced expression towards lsrR by 65% in WT and 
50% in CB11 (∆lsrR) strains, while C2 dropped levels measured toward lsrA by 83% 
in the WT and 46% in CB11.   
Mutation of both C1 and C2 simultaneously returned bi-directional expression 
to minimal levels directly comparable to adjacent CRP-transcriptional start site 
schema (Figure 4-2).  Although expression changes appeared to be more drastic in the 
WT strains, inherent error of β-galactosidase assays at very low expression levels are 
significant (up to ±30%).  As a result, the effect of CRP site mutations is likely more 
representative in CB11, in which LsrR repression is absent and expression levels are 
higher with less standard error.  Additionally, expression patterns in the WT and 
CB11 strains were similar, and no cases were observed in which expression levels 
increased in the presence of LsrR.  That is, LsrR showed no activation effect under 
the conditions tested.   
Notably, mutations in either CRP binding site did not reduce the effect of 
LsrR repression in the opposite direction.  For example, mutation of C1 still resulted 
in an expression difference in WT and CB11 (∆lsrR) strains toward lsrR (pcrp22 in 
Figure 4-2) correlating to approximately 80% repression due to LsrR, similar to that 










Figure 4-2.  Effects of site mutations on lsr divergent gene expression.   
Mutations to selected locations in the intergenic region are indicated by an ‘X’ 
underneath the corresponding sites shown at the top.  After mutations, entire region 
was inserted into the MCS of pFZY1, a low-copy mini-F derivative with a multiple 
cloning site located upstream of a promoterless galK'-lacZYA reporter segment.  Each 
region was inserted into pFZY1 in both coding directions; plasmid names flanking 
each mutated region indicate the construct measuring expression in that direction.  
CRP site mutations (above dashed line) were measured in E. coli K12 WT and CB11 
(∆lsrR) strains in order to confirm LsrR activity as a repressor only.  ‘% Exp.’ 
represents the percent of expression measured with each mutation set using the native 
intergenic region, represented by plsrA14 and plsrR26, as full expression levels.  
Operator and negative control (O1-O4 and P1-P2 sites, respectively; below dashed 
line) expression values were also measured in WT and CB11 strains.  ‘% Rep.’ 
indicates the percentage of repression by LsrR for each individual region, measuring 
the difference in expression for WT and CB11 strains and comparing to complete 
expression (CB11).  All values under WT and CB11 in each column are standard 
Miller Units.  Expression assays were conducted in triplicate and are within ±5% 
error with the exception of values under 20 MU, which are ±10-30%.  Plasmid names 
in bold indicate constructs which reduce the amount of LsrR repression by ≥ 96% in 
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gene located proximally to the mutated CRP site is unclear.  That is, reduced 
expression levels in, for example, the direction of lsrA using pcrp9 (Figure 4-2) may 
be due to LsrR repression or greatly reduced recruitment of RNAP because of lack of 
CRP due to mutation at C1. 
 
Complete LsrR repression is dependent upon binding of two identical 
palindromic half-sites in the divergent lsr promoter region.  In order to build a 
comprehensive model for gene expression and regulation in the lsr intergenic region 
we examined the upstream loci for lsrR and lsrA for potential repressor binding sites.  
Previous work indicates two 30-bp LsrR binding boxes exist in the upstream regions 
of lsrR and lsrA, and deletions and mutations of sections within each box affected 
LsrR binding in β-galactosidase activity assays [22].  However, the interspersed, A-T 
rich homology of the proposed 30-bp alignments suggests possible incongruity with a 
typical helix-turn-helix (H-T-H) binding motif that is predicted for LsrR.   
Specifically, the SorC family of transcriptional regulators, in which LsrR is 
categorized, has a H-T-H binding domain that binds to a typical consensus DNA 
motif of two conserved 6 to 9 base-pair (bp) segments separated by a 6 to 8 bp spacer 
[125-127].   
After further examining the proposed LsrR binding regions, two identical 
palindromic sequences were discovered either overlapping or immediately adjacent to 
the sites indicated previously [22], with the sequence TGAACA-21-TGTTCA lying 
at -16 and -31 of the lsrR and lsrA start sites, respectively (Figure 4-1B, Section 4.6, 




H-T-H consensus motifs; however, previous work has shown that regulators in the 
SorC family which also function in multimeric form in vivo are dependent upon 
adjacent operator sites up to 20 bp long, each containing a palindromic half-site [69, 
128].  Using motif-based computer sequence analysis (http://meme.nbcr.net)[109] 
and manual sequence alignment we could find no other instances of this exact 
palindrome in the entire E. coli K12 genome.   
Previous genomic binding studies using LsrR also report limited binding sites 
for the repressor in S. typhimurium and E. coli [49]. Given this apparent uniqueness 
and localization to the lsr intergenic region, we sought to evaluate the importance and 
effect of the palindrome on LsrR binding and divergent expression in the lsr regulon.  
When motifs for DNA-binding proteins are evaluated, one half of the binding site 
may be more highly conserved or specifically bound, and studies of multimeric 
repressors of divergent gene sets have shown simultaneous binding to two widely 
separated operator pairs [69, 83, 128, 129].  Therefore, in order to fully understand 
the importance of distinct segments of the palindrome on LsrR binding and 
subsequent expression we designated each palindromic half-site as a separate operator 
site (O1 through O4 in Figure 4-1A,B).   
We constructed multiple pFZY1 fusions containing the lsr intergenic region 
with various sets of mutated operator sites and measured resulting bi-directional 
expression in both WT and CB11 (∆lsrR) strains.  Simultaneous mutation of the 
palindromic half-sites O1 and O4 (located proximally to each divergent gene start 
site) resulted in expression levels in WT comparable to those in CB11 when 




plsrR33), indicating a complete elimination of the effect of LsrR when these 
mutations were present.   
Mutations of the O2-O3 half-sites located further from the transcription start 
sites showed a reduction in LsrR repression by 32% and 26% toward lsrR and lsrA, 
respectively; interestingly, however, although the repressive effect of LsrR observed 
in this mutation set measured in the direction of lsrR declined, overall lsrR expression 
increased drastically in both the WT and CB11 strains (Figure 4-2).  Notably, the 
large increase in expression toward lsrR was also present in all plasmid constructs 
carrying a mutation in site O3.  Additional mutation combinations resulted in either 
the complete or partial elimination of LsrR repression in a single direction.  
Surprisingly, however, full palindrome mutations (O1-O2 or O3-O4) on either side of 
the lsr intergenic region had little apparent impact on LsrR regulation of expression 
towards lsrA.  Mutation of O1-O2 also showed minimal effect in the direction of lsrR; 
however, mutation set O3-O4 did reduce LsrR repression toward lsrR from 80% to 
52% (Figure 4-2, plsrR25).   
Next, in order to show that other mutations outside the evaluated palindrome 
in the lsr operon promoter region did not have these same effects on LsrR binding, we 
constructed reporter plasmids carrying mutations from -5 to -10 from the lsrA and 
lsrR start sites (denoted as P1 and P2 in Figure 4-1B) and measured expression in 
both directions.  We also constructed plasmids containing these mutations in 
conjunction with previously included half-site mutations (Figure 4-2, plsrR35-
plsrA46).  Results of each single mutation showed reduced expression levels in the 




reduction in the effect of LsrR binding.  Combinations of P1 or P2 with operator site 
mutations resulted in generally lower expression levels when mutations were 
proximally located to gene start sites.  For example, mutation of P1 and O3 (plsrA36, 
plsrR35) reduced lsrA expression levels in both the WT and CB11 strains by 
approximately half, with lsrR expression mirroring levels similar to those seen with 
other O3 mutations (plsrR31, plsrR27).  Given the pattern of lower expression levels 
and maintained effect of LsrR we hypothesize that these mutation sets primarily 
interfere with RNA polymerase holoenzyme (RNAP) or sigma-factor binding.   
 
4.5 Discussion 
The repressor, LsrR, has been hypothesized as the single expression-regulating 
mechanism in the AI-2 QS ‘circuit’ and has recently garnered more focus for its local 
and global reach [18, 22, 49].  LsrR has been shown to regulate both the lsr operon 
and itself [21, 27] and our more recent work concerning the divergent nature of the 
regulatory network also revealed greater expression rates in the direction of the lsr 
operon (Byrd et al., submitted for publication).  However, no study has yet 
considered the dynamics of the disparate CRP or LsrR binding sites within the lsr 
intergenic region and whether regulation is a result of separate activation or 
repression of lsrR and the lsr operon, or if there is an interdependence of the entire 
region on expression of these QS genes.  In this study we investigated the lsr 
intergenic region in its entirety, accounting for the directional impacts of CRP 
activation and LsrR repression in order to construct a model for expression control of 




 CRP is a global activator in E. coli and functions by binding in upstream 
promoter regions and increasing the ability of RNA polymerase to bind and initiate 
gene transcription [61, 72].  In the lsr intergenic region, the single and double 
mutations of CRP binding sites C1 and C2 show the involvement of both CRP 
proteins for expression of lsrR and the lsr operon (Figure 4-2).  Mutation of the CRP 
binding site adjacent to the RNAP initiation site almost completely eliminated 
proximal protein expression.  In the case of C1, mutation abolished expression of 
lsrA.  Of note, this was irrespective of the presence or absence of LsrR.  Thus, CRP is 
apparently required for transcription of the lsr operon.  The exact converse scenario 
was also found.  That is, mutation of C2 eliminated expression in the direction of 
lsrRK.  Interestingly, the C1 mutation also reduced the transcription of lsrRK and C2 
reduced that of the lsr operon.  These sites were not originally thought to provide 
cooperativity.  Also, it was noteworthy that LsrR was still functional with both of 
these mutations.  
This combinative dependency on both sites qualifies the lsr regulon as a class 
III CRP-dependent promoter (Figure 4-3), at which one α subunit C-terminal domain 
(αCTD) of RNAP interacts with the downstream CRP dimer subunit of C1, one 
αCTD interacts with the upstream subunit of CRP at C2, and the downstream subunit 
of CRP at C2 interacts with RNAP α subunit N-terminal domain (αNTD).  When 
bound, CRP can then coordinate to control regulation through multiple and 
sometimes remote operator sites to which their individual repressors bind [104, 130].  
























Figure 4-3.  Schematic model of CRP-R0AP complex in the lsr regulon.   
Dependency upon both CRP sites simultaneously for full divergent expression 
qualifies the lsr intergenic region as a class III CRP-dependent promoter.  In this 
mechanism, the α subunit C-terminal domains (αCTD) of RNAP interact concurrently 
with the downstream CRP dimer subunit of C1 and the upstream subunit of CRP at 
C2, while RNAP α subunit N-terminal domain (αNTD) interacts with the downstream 















uncommon, as illustrated in the models of the lac, deo, and ara operons [82, 132-
134].   
We also sought to thoroughly examine the binding motif for LsrR, and typical 
protein-DNA binding studies often include in vitro assays such as EMSA in order to 
evaluate changes in protein affinity to DNA sequences carrying mutations or 
deletions in the native binding region.  However, the challenges of in vitro work with 
LsrR have been noted previously [22, 51] and continued efforts to modify conditions 
for LsrR purification and use have not been successful to date.  As a result, we 
designed a series of in vivo reporter plasmids carrying the native lsr intergenic region 
and replicate sets with mutations at putative LsrR binding sites as well as other points 
outside the suspected binding region (Figure 4-2).  In our previous study we showed 
that lsrA is more strongly expressed under normal conditions than lsrR (Byrd et al., 
submitted for publication); therefore, we continued to factor directionality by 
inserting each mutated intergenic region in opposite directions into separate reporter 
plasmids, resulting in two plasmids for each mutation set.  These sets were 
subsequently transformed into E. coli K12MG1655 and CB11 (∆lsrR) in order to 
evaluate the effect of the carried promoter mutations on LsrR binding and repression.   
Our results show an elimination of LsrR repression of lsrA when the staggered 
O1-O3 or O2-O4 operator mutations are present (Figure 4-2).  In the direction of lsrR 
the O1-O3 mutation reduced LsrR repression by 33%; however, the O2-O4 mutation 
had no apparent effect in the same direction.  In the medial O2-O3 mutation set, LsrR 




26% and 32%, respectively.  Most notably, the effects of repression by LsrR are 
completely eliminated in both directions when operators O1 and O4 are mutated.   
The observation that divergent LsrR repression is entirely eliminated when 
both O1 and O4, but not combinations thereof, are mutated suggests a dependence 
upon repressor interaction with both palindromic operator regions simultaneously.   
This, in addition to our findings that for normal expression in the lsr region both CRP 
proteins are bound at once, we propose here that transcriptional control of the lsr 
regulon incorporates DNA looping as part of its mechanism of regulation.  DNA 
looping has become recognized as a centrally involved mechanism in expression 
control and is demonstrated in nearly every model of regulation in which CRP has a 
role; in addition to its function as an activator, CRP bends DNA from 90-125 degrees 
and facilitates the formation of DNA-repressor loops in other models [69, 74, 88].   
Very surprisingly, mutations of O1-O2 did not show a significant reduction in 
LsrR repression in either direction, while the O3-O4 mutation set reduced the effect 
of LsrR by 28% only in the direction of lsrR.  Like varying operator effects seen in 
the lac and deo operons [82, 135], we postulate that the lsr operator sites also vary in 
their impact on expression in the lsr regulon and the effect of DNA bending can 
recruit distal regions to a promoter site.  As a result, while LsrR binding to one full 
palindromic site may be inhibited, DNA conformation due to CRP and other proximal 
interactions could maintain the lsr intergenic region in a looped state.  Analogous to 
RepA repression, LsrR may impede RNAP-DNA binding events while in the vicinity 
of a promoter but not directly bound [90, 136], allowing, for example, LsrR bound at 




Although the effect of LsrR repression toward lsrR may be reduced using 
different mutation sets, we note again that in each plasmid construct carrying an O3 
mutation lsrR expression levels in both the WT and CB11 strains were dramatically 
increased.  These repeated expression level increases only toward lsrR suggest that a 
previously unreported layer of repression may also be present in addition to LsrR.  In 
the divergently transcribed ula regulon and hpt-gcd gene set, each of which also 
incorporates various CRP and operator sites, similar increases in expression were 
noticed when the IHF binding site was mutated or expression activity was measured 
in cells deficient in IHF [63, 69].  Given our observation that expression values 
increase substantially beyond those measured in an lsrR mutant, we hypothesize that 
the lsr regulon also incorporates an additional IHF-like regulatory mechanism that is 
heavily dependent upon the operator O3 for expression control.  Our search for IHF 
binding sequences in the lsr intergenic region produced several potential sites.  
However, the consensus sequence for IHF in E. coli is loosely conserved and difficult 
to predict and determining positive IHF binding sites in the lsr region awaits further 
study [137-139].  
In our previous study we reported a native bias in expression resulting in 
approximately 1.5-fold greater facultative expression towards the lsr operon (Byrd et 
al., submitted for publication).  However, our current results illustrate that although 
lsrA is more highly expressed than lsrR under normal conditions, potential expression 
levels for lsrR are up to 11-fold higher in WT E. coli K12 when operator site O3 is 
mutated.  We found no operator mutations that produced the same increased 




complete elimination of the effect of LsrR in the direction of lsrA while only one 
produced the same effect toward lsrR (Figure 4-2, bold).  The finding that LsrR 
repression is relieved from the lsrA promoter under various conditions, coupled with 
the newly realized potential strength of the lsrR promoter, suggests that LsrR affinity 
and subsequent repression is less specific in the lsrA promoter region than in that for 
lsrR.  In addition, the observation that LsrR can continue to regulate expression in the 
direction of lsrR with different mutations present indicate a more specific affinity for 
the lsrR promoter region.   
Considering the complete relief of LsrR repression seen with the O1-O4 
mutation set, we postulate that these two operators are the primary binding sites for 
LsrR with the medial palindromic half-sites O2-O3, shown to partially relieve LsrR 
repression in each direction, being involved as secondary sites.  Also, when the O1-
O4 mutations were present, no drastic increases in expression were observed as 
previously noted with mutations of O3, indicating also that O1 and O4 are not 
involved in the secondary IHF-like regulation system we propose.  LsrR and UlaR are 
both members of the SorC family of transcriptional regulators, and the lsr and ula 
regulons demonstrate significant structural similarities as well [17, 69, 128].  LsrR 
was previously determined to exist in vivo in dimeric form [52]; however, we offer 
that LsrR actively functions as a tetramer through interaction with flanking operator 
sites and itself simultaneously as is commonly found in repressor-DNA loop schema 
(Figure 4-4) [89, 124, 128, 131].  UlaR was demonstrated to maintain a 





























Figure 4-4.  Proposed model for LsrR repression.   
DNA interaction with CRP bound to sites C1 and C2 results in a looped DNA 
complex with each operator site bound by an LsrR tetramer, repressing transcription 
of lsrR and lsrA.  After interaction with phospho-AI-2, LsrR dimerizes and 
dissociates from operator sites O1-O4, permitting active transcription of both 
divergent genes.  Stoichiometric ratio of one molecule of phospho-AI-2 per LsrR 







hypothesize that, given the functional and structural similarities to UlaR (Section 4.6, 
Supplemental Data), LsrR binds one molecule of phospho-AI-2 per dimer.  However, 
further study is required to determine precise phospho-AI-2/LsrR stoichiometry and 
potential secondary protein interactions in the vicinity of operator sites O2 and O3 
which may hinder or enhance LsrR binding. 
 E. coli K12 is able to use L-ascorbate as a carbon source through fermentation 
via the ula regulon [140].  The ula operon, consisting of six genes (ulaA, B, C, D, E, 
and F)(Figure 4-5A) comprise a PTS system reported to convert L-ascorbate to d-
xylulose 5-phosphate, an intermediary in the pentose phosphate pathway.  The 
divergently oriented gene ulaG encodes a metal-dependent hydrolase which further 
utilizes ascorbate, and ulaR, located downstream of ulaG, encodes the repressor for 
the ula regulon [140, 141].    Similarly to the lsr regulon, in which the cognate 
repressor LsrR is antagonized by the phosphorylated form of AI-2, L-ascorbate-6-
phosphate, converted from L-ascorbate through interaction with UlaA, UlaB, and 
UlaC, binds to and prevents UlaR from repressing transcription of the ula regulon 
[142].   
 Because of the structural similarity of natural furanones such as L-ascorbate to 
that of AI-2 (Figure 4-5B), their application has been postulated to potentially inhibit 
the AI-2 QS response in bacteria [12, 143].  In a bioluminescence assay using V. 
harveyi and C. perfringens, increasing levels of both ascorbic acid and sodium 
ascorbate resulted in decreased luminescent response, likely due to their occupation 
of AI-2 receptors in the reporter strain [143].  However, a co-culture of five separate 
























Figure 4-5.  L-ascorbate utilization in E. coli. 
(A) The ula regulon, indicated for the utilization of L-ascorbate in E. coli [142].  (B)  
Structural similarities of L-ascorbate and two epimeric furanoses formed after 
cyclization of DPD, (2R,4S)- and (2S,4S)-2,4-dihidroxy-2-methyldihydrofuran-3-one 




present showed little variation in growth versus a negative control, although [143].   
While L-ascorbate did not demonstrate a drastic reduction in growth of C. perfringens 
in the studied case, the reduction of the luminescent response in the V. harveyi 
reporter strain shows the potential for ascorbate or other natural furanones as AI-2 
analogs or potentially as cooperative sensing mechanisms in bacteria.    
Although previous studies have approached the lsr intergenic region as two 
oppositely oriented promoters [22, 27], our results clearly show that dependencies 
upon interaction from remote portions of the region affect repression and activation of 
each divergent gene set and that the lsr quorum sensing genes are likely regulated as 
part of a DNA-CRP-LsrR complex, as is common in systems regulated by the SorC 
family of repressors [69, 87, 114].  The observation that various instances exist in 
which repression is completely relieved from lsrACDB but not lsrR imply a less 
stringent regulation of the AI-2 transport gene, potentially contributing to the native 
expression bias toward lsrA we reported previously (Byrd et al., submitted for 
publication).   
We have described for the first time the surprisingly strong potential 
expression of lsrR and its control by an additional putative layer of regulation by an 
IHF-like system separate from LsrR.  However, conditions which stimulate lsrR 
expression and the exact system which specifically adds to its regulation require 
further examination.  Also, that the putative nature of LsrR regulation may vary from 
dimer to tetramer is potentially interesting since this is a QS regulator, and members 
of this family are thought to have sharp or controllable ‘switching’ characteristics 




of LsrR are significant, and understanding the mechanism and circumstances which 
facilitate such a response will help to better understand the QS process.   
 
4.6 Supplemental Data 
lsr promoter region sequence alignment.  Cross-species investigations of DNA 
homology in upstream promoter regions have been recognized to provide 
identification of conserved regulatory protein (primarily transcription factor) binding 
sites and, as a result, aid in identifying transcriptional regulatory networks and 
systems [91, 96, 146].  As discussed in section 4.4, the palindrome 5’-TGAACA-21-
TGTTCA-3’ is indicated to be a putative binding site for the QS regulator LsrR.  In 
order to examine the phylogenetic conservation of this palindrome, we selected 12 
alternate bacterial species which were previously reported to contain QS othologs for 
all proteins encoded via the lsr operon in E. coli (Table 4-2) [147].  For each strain, 
the entire putative lsr intergenic region was extracted from GenBank 
(http://www.ncbi.nlm.nih.gov/genbank/) and aligned using ClustalW alignment tool 
(ClustalW Ver. 2.1, http://www.clustal.org/).  Resulting data were visualized using 
CINEMA (Colour INteractive Editor for Multiple Alignments v. 2.1). 
 Sequence alignments show strong conservation of the palindromic LsrR 
binding sites previously designated as O1 though O4 in Figure 4-1A (single boxes in 
Figure 4-5).  Operator site O1 is completely conserved across all species investigated, 
while O2 has complete conservation with the exception of Pasteurella multocida str. 





Table 4-2.  Bacterial strains used in this study. 
 
GenBank Accession Number                    Description 
  
U00096.2 Escherichia coli str. K-12 substr. MG1655 
 CU928158.2 Escherichia fergusonii ATCC 35469 
NC003197.2 Salmonella enterica Typhimurium str. LT2 
CP001918.1
 
Enterobacter cloacae ATCC 13047 
NC004741 Shigella flexneri 2a str. 2457T 
CP001891.1 Klebsiella variicola At-22 
CP000964.1 Klebsiella pneumoniae 342 
AE004439.1 Pasteurella multocida str. Pm70 
AM286415.1 Yersinia enterocolitica str. 8081 
CP000436.1 Haemophilus somnus 129PT 
BX571869.1 Photorhabdus luminescens subsp. TTO1 
CP001048.1 Yersinia pseudotuberculosis PB1/+ 
























































Figure 4-6.  Cross-species lsr intergenic sequence alignment. 
Sequences corresponding to intergenic regions for twelve bacterial species shown to 
have orthologous genes to the lsr regulon in E. coli were compared.  Species selected 
for comparison are listed to left of first base pair for each region.  Base pair 
designations are: adenine - A (green), thymine - T (red), cytosine - C (blue), guanine - 
G (yellow).  Dashes represent blank positions.  CRP and putative LsrR binding 
regions show high conservation between species and are indicated by solid boxes (O1 
through O4) and double boxes (C1 and C2).  Additional sections were noted 
containing A-T rich (<80%) regions lying between palindromic half sites (dashed 
























































showed five strains with complete homology to E. coli K12, and another three with a 
single base-pair mismatch.  Four strains, Haemophilus somnus 129PT, Photorhabdus 
luminescens subsp. TTO1, Yersinia pseudotuberculosis PB1/+, and Yersinia pestis str. 
Angola, demonstrate little homology to operator site O3.  Similarly, alignments for operator 
site O4 show four strains with complete matches and an additional three strains with a 
single base-pair mismatch.   Strain Yersinia enterocolitica str. 8081, in addition to the four 
strains showing a complete base-pair mismatch with operator site O3, also had 
minimal conservation for O4. 
 cAMP-CRP binding sites are also well conserved between species, showing 
high homology between sequences for both C1 and C2 (double boxes in Figure 4-5).   
In C1, all evaluated species with documented CRP motifs show the consensus half-
site 5’-TCACA-3’ (5’-TCACG-3’ in Salmonella enterica) with the exception of Yersinia 
pestis, for which the lsr intergenic sequence is limited, and Photorhabdus luminescens, which 
shows a single base pair mismatch [86, 148-150].  Similarly to operator sites O3 and O4, site 
C2 also shows slightly lower conservation of DNA sequence between species than the 
corresponding site proximally located to lsrA.  Only three strains, Yersinia enterocolitica str. 
8081, Haemophilus somnus 129PT, and Yersinia pseudotuberculosis PB1/+ demonstrate 
variation from the consensus sequence, with three or fewer base-pair differences present. 
 Alignment of the lsr intergenic regions also demonstrates notable similarities in 
other segments.  First, the sections between palindromic half-sites show A-T rich 
(approximately 80%) DNA segments (dashed boxes in Figure 4-5).  While difficult to 
predict, such segments may indicate increased DNA flexibility or conformational 




additional 21-bp A-T rich area is located at approximately bp 115-136, flanking the 
CRP binding site C1.  
Previous work has compared genes in the lsr regulon and the potential impact 
of orthologous proteins among various species for detection of AI-2 [147].  Although 
exact roles of these newly identified sections demonstrating high conservation are 
impossible to predict without further study, the intergenic regions are also a 
promising location to evaluate similarities among species in order to better 
understand the QS regulatory process and commonalities of AI-2 detection. 
 
Preliminary structural comparison of LsrR, DeoR, and UlaR.  As discussed in 
Sections 2.5 and 4.4, LsrR is categorized in the SorC family of transcriptional 
regulators, and according to I-TASSER structural prediction analysis holds high 
similarity to DeoR, regulator of distinct both sugar-binding and DNA-binding 
domains and transition from bound (repressive) to unbound upon binding their 
appropriate effectors [67, 128].  These effectors, L-ascorbate-6-phosphate and 
deoxyribose-5-phosphate for UlaR and DeoR, respectively, are phosphorylated before 
antagonizing the repressors similar to AI-2 prior to interaction with LsrR [22, 51].    
 Secondary structure prediction (UniProt) indicates domain similarities for 
LsrR to UlaR as well as DeoR.  Given the strong predicted similarities, tertiary 
structural comparison was conducted by submitting the amino acid sequence for 
DeoR and UlaR to I-TASSER protein prediction server and visualizing the result 
using Jmol  (See section 3.3, Materials and Methods).  Results indicate clear 




















Figure 4-7.  Preliminary structural comparison of DeoR, UlaR, and LsrR. 
Front (left column) and side (right column) view of computed DeoR, UlaR, and LsrR 
tertiary structures.  Predicted sugar-binding (red brackets) and DNA-binding (blue 
brackets) domains are indicated.  Tertiary structure prediction for each protein was 
completed using I-TASSER Protein Structure and Function Prediction server 
(http://zhanglab.ccmb.med.umich.edu/I-TASSER/) and van der Waals surface was 




































protein structure indicates a sugar-binding domain distinct from the DNA-binding 
domain, and basic forms appear similar from front and side views.   
 Other proteins with similar functions have been previously characterized and 
demonstrate comparable compositions.  For example, arabinose-binding protein 
(ABP), galactose binding protein (GBP), sulfate-binding protein (SBP), ribose-
binding protein (RBP), and four others all have two distinct lobes connected by two 
to three connecting strands [154, 155].  LsrR has also demonstrated binding to 
multiple sites simultaneously in vivo similar to UlaR and DeoR (See section 4.5, 
Discussion).  While conclusive functional similarities between proteins based solely 
upon structural analysis cannot be confirmed, these apparent similarities further 
support the hypothesis that LsrR, like UlaR and DeoR, functions in vivo as a tetramer 
























Chapter 5: Summary  
 
5.1 Summary of Results 
In this dissertation, the regulatory effects and scope of the QS repressor LsrR were 
examined and impacts of the activator CRP in the lsr intergenic region were explored.  
The focus was to better understand the genetic impact of QS circuitry and construct a 
more accurate model of regulation within the lsr regulon. 
 In Chapter 2, a plasmid vector encoding lsrR was constructed and an N-
terminus His-tagged LsrR was cultured.  The challenges of protein purification with 
the repressor due to insolubility under various conditions were discussed.  In vitro 
analysis of harvested LsrR showed undetectable DNA binding activity to the lsr 
intergenic region, and the addition of the activator CRP did not enhance or otherwise 
promote LsrR binding under tested conditions.  Two sites for CRP binding in the 
intergenic region were confirmed, and binding affinity was shown to be similar 
between the sites despite differences in specific DNA sequences. 
 In Chapter 3 genomic binding site analysis was conducted using DNA 
microarrays and constructing a C-terminus LsrR, which displayed better DNA 
binding activity and in vitro characteristics.  The results showed four putative binding 
sites for LsrR in the E. coli genome, three of which (lsrR-lsrA, yegE-udk, mppA) have 
direct potential connection to the QS response.  Also, divergent expression analysis in 
the lsr regulon revealed a natural expression bias in the direction of lsrACDBFG, 
which encodes the AI-2 import and degradation proteins.  Implications of a 




 Chapter 4 introduced specific putative binding sites for LsrR in the lsr regulon 
and utilized extensive mutation sets in the lsr intergenic region in conjunction with 
divergent expression analysis in order to narrow the impact of the various sites.  
Similar analysis of individual CRP binding sites and their impact upon divergent 
expression were conducted, indicating the lsr region to be a class III CRP-dependent 
promoter, in which both CRP proteins simultaneously contribute to transcriptional 
activation in each direction.  Finally, a proposed model for regulation of the lsr 
regulon was presented incorporating LsrR, CRP, DNA looping, and a secondary layer 
of repression by an IHF-like protein.   
  
5.2 Future Directions 
In vivo activity and analysis of LsrR permitted the collection of data necessary to 
construct a putative model of regulation in the lsr operon.  However, various aspects 
of LsrR characteristics and activity are still unclear.  Efforts to stabilize LsrR and 
increase protein solubility and purification yields for in vitro analysis would permit 
more exhaustive analysis of LsrR binding sites and provide the ability to confirm a 
consensus motif.  
 There appears to be a discrepancy between the unexpectedly few genes 
directly regulated by LsrR and the wide genetic and phenotypic impacts of the QS 
process.  If LsrR is the primary regulator for the QS circuit, further work may 
examine subsequent transcriptional activity beyond LsrR derepression in the lsr 
intergenic region and determine downstream impacts of the genes that were indicated 




 The proposed model for the LsrR-CRP-DNA complex presented in this 
dissertation also discusses for the first time an additional layer of regulation in the lsr 
regulon.  When this layer of repression was relieved via DNA sequence mutations, 
expression of lsrR increased by up to 11-fold.  Similar models of divergent 
transcriptional regulation in which drastic increases in expression were measured 
showed the involvement of integration host factor (IHF) as part of the regulatory 
mechanism.  This putative model can be confirmed by obtaining IHF and conducting 
in vitro or in vivo analysis to explore the lsr intergenic region for potential binding 
sites.  IHF can then be incorporated into the model for lsr regulation and its impacts 
on the QS process can be considered.   
 An alternate possibility for the additional layer of regulation in the lsr regulon 
is the formation of DNA hairpin, cruciform, or other structural DNA formations.  If 
these structural changes exist, the palindrome explored in Chapter 4 will likely be 
involved and the resulting RNA formation and subsequent rates of transcription will 
be affected.  Microbiological assays to explore the effect of these various DNA 
structures will help show their impact on the QS process and their potential 
contribution to the switch-like effect commonly seen in QS circuits.   
Finally, alignment of the intergenic sequences of multiple strains of E. coli 
and the closely related S. flexneri showed conservation of the LsrR and CRP binding 
motifs that were evaluated in this dissertation.  In addition to these species, however, 
the same motifs for the LsrR palindrome presented for E. coli were also discovered in 
S. enterica which is further removed phylogenetically but displays a similar AI-2 




sets homologous to the lsr regulon in E. coli may allow a further refinement of the 
regulatory module which controls these genes as well as provide greater insight into 
the similarities of the QS process among various bacterial species.   
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